<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:TRAD="http://apextech-inc.com/20260831"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2026"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="trad-20260831.xsd" xlink:type="simple"/>
    <context id="From2025-09-01to2026-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="From2025-09-012026-08-31_custom_UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOneRightToReceiveOnefourth14OfOneOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOneRightToReceiveOnefourth14OfOneOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="From2025-09-012026-08-31_custom_OrdinarySharesParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:OrdinarySharesParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="From2025-09-012026-08-31_custom_RightsEachEntitlingHolderToReceiveOnefourth14OfOneOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:RightsEachEntitlingHolderToReceiveOnefourth14OfOneOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-02-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
        </entity>
        <period>
            <instant>2026-02-27</instant>
        </period>
    </context>
    <context id="AsOf2026-10-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
        </entity>
        <period>
            <instant>2026-10-27</instant>
        </period>
    </context>
    <context id="From2026-06-012026-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
        </entity>
        <period>
            <startDate>2026-06-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="AsOf2025-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
        </entity>
        <period>
            <instant>2025-08-31</instant>
        </period>
    </context>
    <context id="From2025-09-012026-08-31_srt_MinimumMember_custom_SubscriptionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">TRAD:SubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="From2025-09-012026-08-31_srt_MaximumMember_custom_SubscriptionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">TRAD:SubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="From2025-09-012026-08-31_custom_SubscriptionAgreementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">TRAD:SubscriptionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-02-27_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-27</instant>
        </period>
    </context>
    <context id="From2026-04-152026-04-15_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-15</startDate>
            <endDate>2026-04-15</endDate>
        </period>
    </context>
    <context id="From2025-08-292025-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
        </entity>
        <period>
            <startDate>2025-08-29</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="From2025-09-012026-08-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="From2025-08-292025-08-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-29</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="From2025-09-012026-08-31_custom_NonRedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="From2025-08-292025-08-31_custom_NonRedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:NonRedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-29</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2025-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-31</instant>
        </period>
    </context>
    <context id="AsOf2025-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-31</instant>
        </period>
    </context>
    <context id="AsOf2025-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-31</instant>
        </period>
    </context>
    <context id="AsOf2025-08-28_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-28</instant>
        </period>
    </context>
    <context id="AsOf2025-08-28_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-28</instant>
        </period>
    </context>
    <context id="AsOf2025-08-28_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-28</instant>
        </period>
    </context>
    <context id="AsOf2025-08-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
        </entity>
        <period>
            <instant>2025-08-28</instant>
        </period>
    </context>
    <context id="From2025-09-012026-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="From2025-09-012026-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="From2025-09-012026-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="From2025-08-292025-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-29</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="From2025-08-292025-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-29</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="From2025-08-292025-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-29</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-08-31_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="AsOf2026-08-31_us-gaap_AdditionalPaidInCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="AsOf2026-08-31_us-gaap_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="AsOf2026-02-26_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-26</instant>
        </period>
    </context>
    <context id="From2026-02-262026-02-27_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-26</startDate>
            <endDate>2026-02-27</endDate>
        </period>
    </context>
    <context id="From2026-02-262026-02-27_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-26</startDate>
            <endDate>2026-02-27</endDate>
        </period>
    </context>
    <context id="From2026-02-262026-02-27_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-26</startDate>
            <endDate>2026-02-27</endDate>
        </period>
    </context>
    <context id="AsOf2026-02-27_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-27</instant>
        </period>
    </context>
    <context id="From2026-04-092026-04-10_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-09</startDate>
            <endDate>2026-04-10</endDate>
        </period>
    </context>
    <context id="AsOf2026-04-10_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-10</instant>
        </period>
    </context>
    <context id="From2026-04-142026-04-15_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-14</startDate>
            <endDate>2026-04-15</endDate>
        </period>
    </context>
    <context id="From2026-04-092026-04-10_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-09</startDate>
            <endDate>2026-04-10</endDate>
        </period>
    </context>
    <context id="AsOf2026-04-10_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-10</instant>
        </period>
    </context>
    <context id="From2026-04-092026-04-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
        </entity>
        <period>
            <startDate>2026-04-09</startDate>
            <endDate>2026-04-10</endDate>
        </period>
    </context>
    <context id="From2026-04-092026-04-10_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-09</startDate>
            <endDate>2026-04-10</endDate>
        </period>
    </context>
    <context id="AsOf2026-04-10_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-04-10</instant>
        </period>
    </context>
    <context id="From2026-02-012026-02-27_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-27</endDate>
        </period>
    </context>
    <context id="AsOf2026-08-31_custom_TrustAccountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">TRAD:TrustAccountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="AsOf2026-08-31_custom_SecuritiesInvestorProtectionCorporationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">TRAD:SecuritiesInvestorProtectionCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="From2025-09-012026-08-31_custom_RedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="From2025-09-012026-08-31_custom_NonRedeemableOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:NonRedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="From2025-08-292025-08-31_custom_RedeemableOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:RedeemableOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-29</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="From2025-08-292025-08-31_custom_NonRedeemableOrdinaryShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:NonRedeemableOrdinaryShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-29</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="From2026-02-062026-02-27_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-02-06</startDate>
            <endDate>2026-02-27</endDate>
        </period>
    </context>
    <context id="From2026-04-142026-04-15_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-04-14</startDate>
            <endDate>2026-04-15</endDate>
        </period>
    </context>
    <context id="From2025-09-012026-08-31_us-gaap_PrivatePlacementMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="From2025-08-292025-08-29_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-29</startDate>
            <endDate>2025-08-29</endDate>
        </period>
    </context>
    <context id="AsOf2025-08-29_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-29</instant>
        </period>
    </context>
    <context id="From2026-01-012026-01-31_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-01-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-01-31_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-01-31</instant>
        </period>
    </context>
    <context id="From2026-08-292026-08-29_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-08-29</startDate>
            <endDate>2026-08-29</endDate>
        </period>
    </context>
    <context id="AsOf2025-08-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
        </entity>
        <period>
            <instant>2025-08-29</instant>
        </period>
    </context>
    <context id="AsOf2025-08-31_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">TRAD:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-31</instant>
        </period>
    </context>
    <context id="AsOf2026-10-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
        </entity>
        <period>
            <instant>2026-10-31</instant>
        </period>
    </context>
    <context id="AsOf2025-10-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
        </entity>
        <period>
            <instant>2025-10-31</instant>
        </period>
    </context>
    <context id="From2025-09-012026-08-31_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">TRAD:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-08-31_custom_SponsorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">TRAD:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="AsOf2026-08-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
        </entity>
        <period>
            <instant>2026-08-20</instant>
        </period>
    </context>
    <context id="AsOf2026-08-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="AsOf2025-08-31_us-gaap_RelatedPartyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-31</instant>
        </period>
    </context>
    <context id="AsOf2026-08-31_us-gaap_IPOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="AsOf2026-02-27_us-gaap_OverAllotmentOptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-02-27</instant>
        </period>
    </context>
    <context id="From2026-02-262026-02-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
        </entity>
        <period>
            <startDate>2026-02-26</startDate>
            <endDate>2026-02-27</endDate>
        </period>
    </context>
    <context id="From2026-02-012026-02-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
        </entity>
        <period>
            <startDate>2026-02-01</startDate>
            <endDate>2026-02-27</endDate>
        </period>
    </context>
    <context id="From2026-05-152026-05-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
        </entity>
        <period>
            <startDate>2026-05-15</startDate>
            <endDate>2026-05-15</endDate>
        </period>
    </context>
    <context id="From2026-07-202026-07-20_srt_ChiefExecutiveOfficerMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-07-20</startDate>
            <endDate>2026-07-20</endDate>
        </period>
    </context>
    <context id="AsOf2026-08-31_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="AsOf2025-08-31_custom_FounderSharesMember_us-gaap_CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:FounderSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-31</instant>
        </period>
    </context>
    <context id="AsOf2026-08-31_custom_FounderSharesMember_custom_PublicRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">TRAD:PublicRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="AsOf2026-08-31_custom_FounderSharesMember_custom_PrivateRightsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">TRAD:PrivateRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="AsOf2025-08-31_custom_FounderSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">TRAD:FounderSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-08-31</instant>
        </period>
    </context>
    <context id="From2025-07-012026-08-31_us-gaap_AllOtherSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-01</startDate>
            <endDate>2026-08-31</endDate>
        </period>
    </context>
    <context id="From2025-08-292025-08-31_us-gaap_AllOtherSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-08-29</startDate>
            <endDate>2025-08-31</endDate>
        </period>
    </context>
    <context id="AsOf2026-08-31_us-gaap_AllOtherSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-08-31</instant>
        </period>
    </context>
    <context id="From2026-10-202026-10-20_custom_KoraiFlixIncMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">TRAD:KoraiFlixIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-10-20</startDate>
            <endDate>2026-10-20</endDate>
        </period>
    </context>
    <context id="AsOf2026-10-20_custom_KoraiFlixIncMember_us-gaap_SubsequentEventMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002085485</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">TRAD:KoraiFlixIncMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-10-20</instant>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="Segment">
        <measure>TRAD:Segment</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2025-09-01to2026-08-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2025-09-01to2026-08-31" id="Fact000004">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="From2025-09-01to2026-08-31" id="Fact000005">0002085485</dei:EntityCentralIndexKey>
    <us-gaap:Cash
      contextRef="AsOf2025-08-31"
      id="xdx2ixbrl0080"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2026-08-31"
      id="xdx2ixbrl0082"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:DeferredCosts
      contextRef="AsOf2026-08-31"
      id="xdx2ixbrl0088"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2025-08-31"
      id="xdx2ixbrl0092"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2025-08-31"
      id="xdx2ixbrl0107"
      unitRef="USD"
      xsi:nil="true"/>
    <TRAD:PromissoryNotesPayableRelatedPartyCurrent
      contextRef="AsOf2026-08-31"
      id="xdx2ixbrl0109"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2026-08-31"
      id="xdx2ixbrl0118"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="AsOf2025-08-31"
      id="xdx2ixbrl0119"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2025-08-31"
      id="xdx2ixbrl0122"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2026-08-31"
      id="xdx2ixbrl0166"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0203"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:OtherIncome
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0206"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-08-292025-08-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember"
      id="xdx2ixbrl0215"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-08-292025-08-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember"
      id="xdx2ixbrl0217"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-08-292025-08-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember"
      id="xdx2ixbrl0223"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-08-292025-08-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember"
      id="xdx2ixbrl0225"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-09-012026-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0269"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts
      contextRef="From2025-09-012026-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0274"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts
      contextRef="From2025-09-012026-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0276"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2025-09-012026-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0279"
      unitRef="USD"
      xsi:nil="true"/>
    <TRAD:AdjustmentsToAdditionalPaidInCapitalAccretionOfCarryingValueToRedemptionValue
      contextRef="From2025-09-012026-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0284"
      unitRef="USD"
      xsi:nil="true"/>
    <TRAD:AdjustmentsToAdditionalPaidInCapitalAccretionOfCarryingValueToRedemptionValue
      contextRef="From2025-09-012026-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0286"
      unitRef="USD"
      xsi:nil="true"/>
    <TRAD:StockIssuedDuringPeriodValueRepresentativeShares
      contextRef="From2025-09-012026-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0291"
      unitRef="USD"
      xsi:nil="true"/>
    <TRAD:AdjustmentsToAdditionalPaidInCapitalOrdinarySharesSubjectToRedemption
      contextRef="From2025-09-012026-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0296"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-09-012026-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0301"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-09-012026-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0302"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0307"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-28_us-gaap_CommonStockMember"
      id="xdx2ixbrl0313"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-28_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0314"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-28_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0315"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-28"
      id="xdx2ixbrl0316"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-08-28_us-gaap_CommonStockMember"
      id="xdx2ixbrl0318"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-28_us-gaap_CommonStockMember"
      id="xdx2ixbrl0320"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-28_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0321"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-28_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0322"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-28"
      id="xdx2ixbrl0323"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-08-28_us-gaap_CommonStockMember"
      id="xdx2ixbrl0325"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2025-08-292025-08-31_us-gaap_RetainedEarningsMember"
      id="xdx2ixbrl0329"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-08-292025-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0334"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-08-292025-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0335"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-08-292025-08-31_us-gaap_CommonStockMember"
      id="xdx2ixbrl0339"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-08-292025-08-31_us-gaap_AdditionalPaidInCapitalMember"
      id="xdx2ixbrl0340"
      unitRef="USD"
      xsi:nil="true"/>
    <TRAD:FormationAndOperatingCostsPaidBySponsor
      contextRef="From2025-09-01to2026-08-31"
      id="xdx2ixbrl0382"
      unitRef="USD"
      xsi:nil="true"/>
    <TRAD:InterestEarnedOnTrustAccount
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0386"
      unitRef="USD"
      xsi:nil="true"/>
    <TRAD:OperatingCostsPaidBySponsor
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0389"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0395"
      unitRef="USD"
      xsi:nil="true"/>
    <TRAD:IncreaseDecreaseInAccountPayableAndAccruedLiabilities
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0398"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0401"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0407"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0410"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0416"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0419"
      unitRef="USD"
      xsi:nil="true"/>
    <TRAD:RepaymentOfPromissoryNoteRelatedParty
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0422"
      unitRef="USD"
      xsi:nil="true"/>
    <TRAD:RepaymentsOfUnderwriterFees
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0425"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0428"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0431"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0434"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0437"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-08-31"
      id="xdx2ixbrl0439"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-08-28"
      id="xdx2ixbrl0440"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2025-08-31"
      id="xdx2ixbrl0443"
      unitRef="USD"
      xsi:nil="true"/>
    <TRAD:RemeasurementOfCarryingValueToRedemptionValue
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0449"
      unitRef="USD"
      xsi:nil="true"/>
    <TRAD:FormationAndOperatingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares
      contextRef="From2025-09-01to2026-08-31"
      id="xdx2ixbrl0451"
      unitRef="USD"
      xsi:nil="true"/>
    <TRAD:PrepaidExpensesPaidBySponsorInExchangeForIssuanceOfOrdinaryShares
      contextRef="From2025-09-01to2026-08-31"
      id="xdx2ixbrl0454"
      unitRef="USD"
      xsi:nil="true"/>
    <TRAD:DeferredOfferingCostsIncludedInAccruedExpenses
      contextRef="From2025-09-01to2026-08-31"
      id="xdx2ixbrl0457"
      unitRef="USD"
      xsi:nil="true"/>
    <TRAD:OperatingCostsPaidBySponsorOnBehalfOfCompany
      contextRef="From2025-08-292025-08-31"
      id="xdx2ixbrl0461"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:Cash
      contextRef="AsOf2025-08-31"
      id="xdx2ixbrl0526"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-08-292025-08-31_custom_RedeemableOrdinarySharesMember"
      id="xdx2ixbrl0583"
      unitRef="USD"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-08-292025-08-31_custom_RedeemableOrdinarySharesMember"
      id="xdx2ixbrl0594"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-08-292025-08-31_custom_RedeemableOrdinarySharesMember"
      id="xdx2ixbrl0596"
      unitRef="Shares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-08-292025-08-31_custom_RedeemableOrdinarySharesMember"
      id="xdx2ixbrl0610"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-08-292025-08-31_custom_RedeemableOrdinarySharesMember"
      id="xdx2ixbrl0612"
      unitRef="USDPShares"
      xsi:nil="true"/>
    <us-gaap:InvestmentTaxCredit
      contextRef="From2025-08-292025-08-31_us-gaap_AllOtherSegmentsMember"
      id="xdx2ixbrl0772"
      unitRef="USD"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2025-09-01to2026-08-31" id="Fact000013">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="From2025-09-01to2026-08-31" id="Fact000014">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2025-09-01to2026-08-31" id="Fact000015">2026-08-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="From2025-09-01to2026-08-31" id="Fact000016">--08-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="From2025-09-01to2026-08-31" id="Fact000017">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="From2025-09-01to2026-08-31" id="Fact000018">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="From2025-09-01to2026-08-31" id="Fact000019">001-43164</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2025-09-01to2026-08-31" id="Fact000020">APEX TECH ACQUISITION INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2025-09-01to2026-08-31" id="Fact000021">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="From2025-09-01to2026-08-31" id="Fact000022">00-0000000</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2025-09-01to2026-08-31" id="Fact000023">13501 Katy Freeway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2025-09-01to2026-08-31" id="Fact000024">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2025-09-01to2026-08-31" id="Fact000025">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2025-09-01to2026-08-31" id="Fact000026">77079</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2025-09-01to2026-08-31" id="Fact000027">(840)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2025-09-01to2026-08-31" id="Fact000028">244-9122</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="From2025-09-012026-08-31_custom_UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOneRightToReceiveOnefourth14OfOneOrdinaryShareMember"
      id="Fact000029">Units,     each consisting of one ordinary share, $0.0001 par value, and one right to receive one-fourth (1/4) of one ordinary share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-09-012026-08-31_custom_UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOneRightToReceiveOnefourth14OfOneOrdinaryShareMember"
      id="Fact000030">TRADU</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-09-012026-08-31_custom_UnitsEachConsistingOfOneOrdinaryShare0.0001ParValueAndOneRightToReceiveOnefourth14OfOneOrdinaryShareMember"
      id="Fact000031">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-09-012026-08-31_custom_OrdinarySharesParValue0.0001PerShareMember"
      id="Fact000032">Ordinary     shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-09-012026-08-31_custom_OrdinarySharesParValue0.0001PerShareMember"
      id="Fact000033">TRAD</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-09-012026-08-31_custom_OrdinarySharesParValue0.0001PerShareMember"
      id="Fact000034">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2025-09-012026-08-31_custom_RightsEachEntitlingHolderToReceiveOnefourth14OfOneOrdinaryShareMember"
      id="Fact000035">Rights,     each entitling the holder to receive one-fourth (1/4) of one ordinary share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2025-09-012026-08-31_custom_RightsEachEntitlingHolderToReceiveOnefourth14OfOneOrdinaryShareMember"
      id="Fact000036">TRADR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2025-09-012026-08-31_custom_RightsEachEntitlingHolderToReceiveOnefourth14OfOneOrdinaryShareMember"
      id="Fact000037">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2025-09-01to2026-08-31" id="Fact000038">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2025-09-01to2026-08-31" id="Fact000039">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="From2025-09-01to2026-08-31" id="Fact000040">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2025-09-01to2026-08-31" id="Fact000041">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="From2025-09-01to2026-08-31" id="Fact000042">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="From2025-09-01to2026-08-31" id="Fact000043">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="From2025-09-01to2026-08-31" id="Fact000044">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="From2025-09-01to2026-08-31" id="Fact000045">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="From2025-09-01to2026-08-31" id="Fact000046">false</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="From2025-09-01to2026-08-31" id="Fact000047">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="From2025-09-01to2026-08-31" id="Fact000048">true</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="AsOf2026-02-27"
      decimals="0"
      id="Fact000049"
      unitRef="USD">0</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2026-10-27"
      decimals="INF"
      id="Fact000050"
      unitRef="Shares">14637000</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityListingParValuePerShare
      contextRef="From2025-09-01to2026-08-31"
      decimals="INF"
      id="Fact000051"
      unitRef="USDPShares">0.0001</dei:EntityListingParValuePerShare>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000052">None</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000056">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span id="aly_005"&gt;&lt;/span&gt;Item
1C. Cybersecurity&lt;/b&gt;&lt;/span&gt;&#160;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
are a blank check company with no operations, no employees other than our two executive officers, and no information technology systems
of our own beyond the personal computing devices and third-party email and cloud services used by our officers and directors. Because
we do not operate a business, we do not currently maintain a formal enterprise cybersecurity program. Our management, and in particular
our Chief Financial Officer, is responsible for assessing and managing the risks from cybersecurity threats that could affect us, principally
the risk of unauthorized access to information concerning potential business combination targets and the risk of fraudulent payment instructions
directed at funds held outside the trust account. &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskBoardOfDirectorsOversightTextBlock_c20250901__20260831_zit1qDsoUob1"&gt;Our board of directors, through its&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250901__20260831_zWxkqahbMMH5"&gt; audit committee, oversees these risks and receives
reports from management&lt;/span&gt; as needed&lt;/span&gt;. We rely on the cybersecurity practices of the &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_906_ecyd--CybersecurityRiskManagementThirdPartyEngagedFlag_dbT_c20250901__20260831_zVKfNesWaqX3"&gt;third-party&lt;/span&gt; service providers on which we depend, including
our transfer agent and rights agent, the trustee of the trust account and our financial reporting and filing agents, and we have not
engaged any assessor, consultant or auditor with respect to cybersecurity. As of the date of this Annual Report, we are not aware of
any cybersecurity incident that has &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_90E_ecyd--CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag_dbF_c20250901__20260831_zjTkNU7KZUH6"&gt;materially&lt;/span&gt; affected, or is reasonably likely to materially affect, us, including our business strategy,
results of operations or financial condition. In connection with our evaluation of any target business, we expect to assess the cybersecurity
risks of that business as part of our due diligence.&lt;/span&gt;&lt;/p&gt;

&#160;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000057">Our board of directors, through its&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEN5YmVyc2VjdXJpdHkgUmlzayBNYW5hZ2VtZW50IGFuZCBTdHJhdGVneSBEaXNjbG9zdXJlAA__" id="xdx_903_ecyd--CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock_c20250901__20260831_zWxkqahbMMH5"&gt; audit committee, oversees these risks and receives
reports from management&lt;/span&gt; as needed</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000058"> audit committee, oversees these risks and receives
reports from management</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="From2025-09-01to2026-08-31" id="Fact000059">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="From2025-09-01to2026-08-31" id="Fact000060">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="From2026-06-012026-08-31" id="Fact000061">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="From2026-06-012026-08-31" id="Fact000062">false</ecd:NonRule10b51ArrAdoptedFlag>
    <TRAD:Rule10b51ArrModifiedFlag contextRef="From2026-06-012026-08-31" id="Fact000063">false</TRAD:Rule10b51ArrModifiedFlag>
    <TRAD:NonRule10b51ArrModifiedFlag contextRef="From2026-06-012026-08-31" id="Fact000064">false</TRAD:NonRule10b51ArrModifiedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="From2026-06-012026-08-31" id="Fact000065">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="From2026-06-012026-08-31" id="Fact000066">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="From2026-06-012026-08-31" id="Fact000067">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <dei:AuditorFirmId contextRef="From2025-09-01to2026-08-31" id="Fact000068">2485</dei:AuditorFirmId>
    <dei:AuditorOpinionTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000069">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;We
have audited the accompanying balance sheets of APEX Tech Acquisition Inc. (the &#x201c;Company&#x201d;) as of August 31, 2026 and 2025,
and the related statements of operations, changes in shareholders&#x2019; (deficit) equity, and cash flows for the years ended August 31,
2026 and for the period from August 29, 2025 (inception) through August 31, 2025, and the related notes (collectively referred to as
the &#x201c;financial statements&#x201d;). In our opinion, the financial statements present fairly, in all material respects, the financial
position of the Company as of August 31, 2026 and 2025, and the results of its operations and its cash flows for the year ended August
31, 2026 and for the period from August 29, 2025 (inception) through August 31, 2025, in conformity with accounting principles generally
accepted in the United States of America.&lt;/span&gt;</dei:AuditorOpinionTextBlock>
    <dei:AuditorName contextRef="From2025-09-01to2026-08-31" id="Fact000070">Simon &amp; Edward, LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2025-09-01to2026-08-31" id="Fact000071">Rowland Heights, California</dei:AuditorLocation>
    <us-gaap:Cash
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000079"
      unitRef="USD">1148</us-gaap:Cash>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000083"
      unitRef="USD">8000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000085"
      unitRef="USD">1148</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000086"
      unitRef="USD">8000</us-gaap:AssetsCurrent>
    <us-gaap:DeferredCosts
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000089"
      unitRef="USD">20000</us-gaap:DeferredCosts>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000091"
      unitRef="USD">116695841</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000094"
      unitRef="USD">116696989</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000095"
      unitRef="USD">28000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000103"
      unitRef="USD">158353</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000104"
      unitRef="USD">20000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000106"
      unitRef="USD">181167</us-gaap:OtherLiabilitiesCurrent>
    <TRAD:PromissoryNotesPayableRelatedPartyCurrent
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000110"
      unitRef="USD">47</TRAD:PromissoryNotesPayableRelatedPartyCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000112"
      unitRef="USD">339520</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000113"
      unitRef="USD">20047</us-gaap:LiabilitiesCurrent>
    <us-gaap:Liabilities
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000115"
      unitRef="USD">339520</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000116"
      unitRef="USD">20047</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2025-08-31"
      decimals="INF"
      id="Fact000124"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="AsOf2026-08-31"
      decimals="INF"
      id="Fact000126"
      unitRef="USDPShares">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2025-08-31"
      decimals="INF"
      id="Fact000128"
      unitRef="Shares">600000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="AsOf2026-08-31"
      decimals="INF"
      id="Fact000130"
      unitRef="Shares">600000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2026-08-31"
      decimals="INF"
      id="Fact000132"
      unitRef="Shares">11500000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="AsOf2025-08-31"
      decimals="INF"
      id="Fact000134"
      unitRef="USDPShares">10.15</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="AsOf2026-08-31"
      decimals="INF"
      id="Fact000136"
      unitRef="USDPShares">10.15</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2025-08-31"
      decimals="INF"
      id="Fact000138"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000121"
      unitRef="USD">116695841</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2025-08-31"
      decimals="INF"
      id="Fact000146"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-08-31"
      decimals="INF"
      id="Fact000148"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-08-31"
      decimals="INF"
      id="Fact000150"
      unitRef="Shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2025-08-31"
      decimals="INF"
      id="Fact000152"
      unitRef="Shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-08-31"
      decimals="INF"
      id="Fact000154"
      unitRef="Shares">3137000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2026-08-31"
      decimals="INF"
      id="Fact000156"
      unitRef="Shares">3137000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2025-08-31"
      decimals="INF"
      id="Fact000158"
      unitRef="Shares">2875000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="AsOf2025-08-31"
      decimals="INF"
      id="Fact000160"
      unitRef="Shares">2875000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2026-08-31"
      decimals="INF"
      id="Fact000162"
      unitRef="Shares">11500000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2025-08-31"
      decimals="INF"
      id="Fact000164"
      unitRef="Shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:CommonStockValue
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000143"
      unitRef="USD">313</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000144"
      unitRef="USD">287</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000167"
      unitRef="USD">24713</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000169"
      unitRef="USD">-338685</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000170"
      unitRef="USD">-17047</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000172"
      unitRef="USD">-338372</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000173"
      unitRef="USD">7953</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000175"
      unitRef="USD">116696989</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000176"
      unitRef="USD">28000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-09-012026-08-31_srt_MinimumMember_custom_SubscriptionAgreementMember"
      decimals="INF"
      id="Fact000179"
      unitRef="Shares">1725000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-09-012026-08-31_srt_MaximumMember_custom_SubscriptionAgreementMember"
      decimals="INF"
      id="Fact000181"
      unitRef="Shares">2875000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-09-012026-08-31_custom_SubscriptionAgreementMember"
      decimals="0"
      id="Fact000183"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2025-09-012026-08-31_custom_SubscriptionAgreementMember"
      decimals="INF"
      id="Fact000185"
      unitRef="Shares">375000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:SharesIssued
      contextRef="AsOf2026-02-27_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000187"
      unitRef="Shares">1197131</us-gaap:SharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2026-04-152026-04-15_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000189"
      unitRef="Shares">302869</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="From2026-04-152026-04-15_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000191"
      unitRef="Shares">2875000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000193"
      unitRef="USD">962124</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2025-08-292025-08-31"
      decimals="0"
      id="Fact000194"
      unitRef="USD">17047</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000196"
      unitRef="USD">-962124</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:IncomeLossFromContinuingOperations
      contextRef="From2025-08-292025-08-31"
      decimals="0"
      id="Fact000197"
      unitRef="USD">-17047</us-gaap:IncomeLossFromContinuingOperations>
    <us-gaap:InvestmentIncomeInterest
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000202"
      unitRef="USD">1695841</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherIncome
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000205"
      unitRef="USD">1695841</us-gaap:OtherIncome>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000208"
      unitRef="USD">733717</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-08-292025-08-31"
      decimals="0"
      id="Fact000209"
      unitRef="USD">-17047</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-09-012026-08-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember"
      decimals="INF"
      id="Fact000211"
      unitRef="Shares">5789768</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-09-012026-08-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember"
      decimals="INF"
      id="Fact000213"
      unitRef="Shares">5789768</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-09-012026-08-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember"
      decimals="INF"
      id="Fact000219"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-09-012026-08-31_custom_OrdinarySharesSubjectToPossibleRedemptionMember"
      decimals="INF"
      id="Fact000221"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-09-012026-08-31_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000227"
      unitRef="Shares">3007404</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-09-012026-08-31_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000229"
      unitRef="Shares">3007404</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-08-292025-08-31_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000231"
      unitRef="Shares">2500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-08-292025-08-31_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000233"
      unitRef="Shares">2500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-09-012026-08-31_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000235"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-09-012026-08-31_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000237"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-08-292025-08-31_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000239"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-08-292025-08-31_custom_NonRedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000241"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-09-012026-08-31_srt_MinimumMember_custom_SubscriptionAgreementMember"
      decimals="INF"
      id="Fact000244"
      unitRef="Shares">1725000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-09-012026-08-31_srt_MaximumMember_custom_SubscriptionAgreementMember"
      decimals="INF"
      id="Fact000246"
      unitRef="Shares">2875000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-09-012026-08-31_custom_SubscriptionAgreementMember"
      decimals="0"
      id="Fact000248"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-09-012026-08-31_custom_SubscriptionAgreementMember"
      decimals="0"
      id="Fact000250"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2025-09-012026-08-31_custom_SubscriptionAgreementMember"
      decimals="INF"
      id="Fact000252"
      unitRef="Shares">375000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:SharesIssued
      contextRef="AsOf2026-02-27_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000254"
      unitRef="Shares">1197131</us-gaap:SharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2026-04-152026-04-15_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000256"
      unitRef="Shares">302869</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="From2026-04-152026-04-15_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000258"
      unitRef="Shares">2875000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000265"
      unitRef="Shares">2875000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000260"
      unitRef="USD">287</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000261"
      unitRef="USD">24713</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000262"
      unitRef="USD">-17047</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000263"
      unitRef="USD">7953</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-09-012026-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000272"
      unitRef="Shares">212000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-09-012026-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000267"
      unitRef="USD">21</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-09-012026-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000268"
      unitRef="USD">2119974</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000270"
      unitRef="USD">2119995</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts
      contextRef="From2025-09-012026-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000275"
      unitRef="USD">2835450</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000277"
      unitRef="USD">2835450</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedOwnshareLendingArrangementIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2025-09-012026-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000280"
      unitRef="USD">-39550</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalOther
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000282"
      unitRef="USD">-39550</us-gaap:AdjustmentsToAdditionalPaidInCapitalOther>
    <TRAD:AdjustmentsToAdditionalPaidInCapitalAccretionOfCarryingValueToRedemptionValue
      contextRef="From2025-09-012026-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000285"
      unitRef="USD">-4377896</TRAD:AdjustmentsToAdditionalPaidInCapitalAccretionOfCarryingValueToRedemptionValue>
    <TRAD:AdjustmentsToAdditionalPaidInCapitalAccretionOfCarryingValueToRedemptionValue
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000287"
      unitRef="USD">-4377896</TRAD:AdjustmentsToAdditionalPaidInCapitalAccretionOfCarryingValueToRedemptionValue>
    <TRAD:StockIssuedDuringPeriodSharesRepresentativeShares
      contextRef="From2025-09-012026-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000294"
      unitRef="Shares">50000</TRAD:StockIssuedDuringPeriodSharesRepresentativeShares>
    <TRAD:StockIssuedDuringPeriodValueRepresentativeShares
      contextRef="From2025-09-012026-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000289"
      unitRef="USD">5</TRAD:StockIssuedDuringPeriodValueRepresentativeShares>
    <TRAD:StockIssuedDuringPeriodValueRepresentativeShares
      contextRef="From2025-09-012026-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000290"
      unitRef="USD">77795</TRAD:StockIssuedDuringPeriodValueRepresentativeShares>
    <TRAD:StockIssuedDuringPeriodValueRepresentativeShares
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000292"
      unitRef="USD">77800</TRAD:StockIssuedDuringPeriodValueRepresentativeShares>
    <TRAD:AdjustmentsToAdditionalPaidInCapitalOrdinarySharesSubjectToRedemption
      contextRef="From2025-09-012026-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000297"
      unitRef="USD">640486</TRAD:AdjustmentsToAdditionalPaidInCapitalOrdinarySharesSubjectToRedemption>
    <TRAD:AdjustmentsToAdditionalPaidInCapitalOrdinarySharesSubjectToRedemption
      contextRef="From2025-09-012026-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000298"
      unitRef="USD">1055355</TRAD:AdjustmentsToAdditionalPaidInCapitalOrdinarySharesSubjectToRedemption>
    <TRAD:AdjustmentsToAdditionalPaidInCapitalOrdinarySharesSubjectToRedemption
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000299"
      unitRef="USD">1695841</TRAD:AdjustmentsToAdditionalPaidInCapitalOrdinarySharesSubjectToRedemption>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-09-012026-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000303"
      unitRef="USD">733717</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000304"
      unitRef="USD">733717</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000311"
      unitRef="Shares">3137000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000306"
      unitRef="USD">313</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000308"
      unitRef="USD">-338685</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000309"
      unitRef="USD">-338372</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2025-08-292025-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000332"
      unitRef="Shares">2875000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2025-08-292025-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000327"
      unitRef="USD">287</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2025-08-292025-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000328"
      unitRef="USD">24713</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:StockIssuedDuringPeriodValueOther
      contextRef="From2025-08-292025-08-31"
      decimals="0"
      id="Fact000330"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueOther>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-08-292025-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000336"
      unitRef="USD">-17047</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-08-292025-08-31"
      decimals="0"
      id="Fact000337"
      unitRef="USD">-17047</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-08-292025-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000341"
      unitRef="USD">-17047</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-08-292025-08-31"
      decimals="0"
      id="Fact000342"
      unitRef="USD">-17047</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000349"
      unitRef="Shares">2875000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000344"
      unitRef="USD">287</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000345"
      unitRef="USD">24713</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000346"
      unitRef="USD">-17047</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000347"
      unitRef="USD">7953</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-08-31_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000356"
      unitRef="Shares">2875000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-31_us-gaap_CommonStockMember"
      decimals="0"
      id="Fact000351"
      unitRef="USD">287</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-31_us-gaap_AdditionalPaidInCapitalMember"
      decimals="0"
      id="Fact000352"
      unitRef="USD">24713</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-31_us-gaap_RetainedEarningsMember"
      decimals="0"
      id="Fact000353"
      unitRef="USD">-17047</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="AsOf2025-08-31"
      decimals="0"
      id="Fact000354"
      unitRef="USD">7953</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-09-012026-08-31_srt_MinimumMember_custom_SubscriptionAgreementMember"
      decimals="INF"
      id="Fact000359"
      unitRef="Shares">1725000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-09-012026-08-31_srt_MaximumMember_custom_SubscriptionAgreementMember"
      decimals="INF"
      id="Fact000361"
      unitRef="Shares">2875000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="From2025-09-012026-08-31_custom_SubscriptionAgreementMember"
      decimals="0"
      id="Fact000363"
      unitRef="USD">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="From2025-09-012026-08-31_custom_SubscriptionAgreementMember"
      decimals="INF"
      id="Fact000365"
      unitRef="Shares">375000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:SharesIssued
      contextRef="AsOf2026-02-27_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000367"
      unitRef="Shares">1197131</us-gaap:SharesIssued>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2026-04-152026-04-15_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000369"
      unitRef="Shares">302869</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="From2026-04-152026-04-15_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000371"
      unitRef="Shares">2875000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000376"
      unitRef="USD">733717</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-08-292025-08-31"
      decimals="0"
      id="Fact000377"
      unitRef="USD">-17047</us-gaap:NetIncomeLoss>
    <TRAD:FormationAndOperatingCostsPaidBySponsor
      contextRef="From2025-08-292025-08-31"
      decimals="0"
      id="Fact000383"
      unitRef="USD">17047</TRAD:FormationAndOperatingCostsPaidBySponsor>
    <TRAD:InterestEarnedOnTrustAccount
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000385"
      unitRef="USD">1695841</TRAD:InterestEarnedOnTrustAccount>
    <TRAD:OperatingCostsPaidBySponsor
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000388"
      unitRef="USD">176167</TRAD:OperatingCostsPaidBySponsor>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000394"
      unitRef="USD">-8000</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <TRAD:IncreaseDecreaseInAccountPayableAndAccruedLiabilities
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000397"
      unitRef="USD">138353</TRAD:IncreaseDecreaseInAccountPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000400"
      unitRef="USD">-639604</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000406"
      unitRef="USD">115000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000409"
      unitRef="USD">-115000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000415"
      unitRef="USD">115000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000418"
      unitRef="USD">2119995</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <TRAD:RepaymentOfPromissoryNoteRelatedParty
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000421"
      unitRef="USD">47</TRAD:RepaymentOfPromissoryNoteRelatedParty>
    <TRAD:RepaymentsOfUnderwriterFees
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000424"
      unitRef="USD">1150000</TRAD:RepaymentsOfUnderwriterFees>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000427"
      unitRef="USD">334196</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromRelatedPartyDebt
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000430"
      unitRef="USD">5000</us-gaap:ProceedsFromRelatedPartyDebt>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000433"
      unitRef="USD">115640752</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000436"
      unitRef="USD">1148</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000442"
      unitRef="USD">1148</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <TRAD:RemeasurementOfCarryingValueToRedemptionValue
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000448"
      unitRef="USD">6113291</TRAD:RemeasurementOfCarryingValueToRedemptionValue>
    <TRAD:FormationAndOperatingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares
      contextRef="From2025-08-292025-08-31"
      decimals="0"
      id="Fact000452"
      unitRef="USD">17000</TRAD:FormationAndOperatingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares>
    <TRAD:PrepaidExpensesPaidBySponsorInExchangeForIssuanceOfOrdinaryShares
      contextRef="From2025-08-292025-08-31"
      decimals="0"
      id="Fact000455"
      unitRef="USD">8000</TRAD:PrepaidExpensesPaidBySponsorInExchangeForIssuanceOfOrdinaryShares>
    <TRAD:DeferredOfferingCostsIncludedInAccruedExpenses
      contextRef="From2025-08-292025-08-31"
      decimals="0"
      id="Fact000458"
      unitRef="USD">20000</TRAD:DeferredOfferingCostsIncludedInAccruedExpenses>
    <TRAD:OperatingCostsPaidBySponsorOnBehalfOfCompany
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000460"
      unitRef="USD">176167</TRAD:OperatingCostsPaidBySponsorOnBehalfOfCompany>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000463">&lt;p id="xdx_804_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_zBWSPxW1xcY3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
1 &#x2014; &lt;span id="xdx_820_z96bvHypdSSk"&gt;Organization, Business Operations&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;APEX Tech Acquisition Inc. (the &#x201c;Company&#x201d;) is a blank check
company incorporated under the laws of the Cayman Islands as an exempted company with limited liability on August 29, 2025. The Company
was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization
or similar business combination with one or more businesses or entities (&#x201c;Business Combination&#x201d;). The Company&#x2019;s efforts
to identify a prospective target business were not limited to a particular industry or geographic region. On October 20, 2026, the Company
entered into the Merger Agreement with Korai described in Note 9. The Company is an early stage and emerging growth company and, as such,
the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company has selected August
31 as its fiscal year end. The Company&#x2019;s founder and sponsor is APEX INNOVATION ACQUISITION CORP., a Delaware corporation (the &#x201c;Sponsor&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of August 31, 2026, the Company had not commenced any operations. For the period from August 29, 2025 (inception) through August 31,
2026, the Company&#x2019;s efforts have been limited to organizational activities as well as activities related to completing the Initial
Public Offering (&#x201c;IPO&#x201d;), as described below, and subsequent to the IPO, identifying a target company for a Business Combination.
The Company will not generate any operating revenue until after the completion of its initial Business Combination, at the earliest.
The Company will generate non-operating income in the form of dividend and/or interest income from the proceeds derived from the IPO
and sale of Private Shares (as defined below).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
registration statement for the Company&#x2019;s IPO became effective on February 25, 2026. On February 27, 2026, the Company
consummated the IPO of &lt;span id="xdx_907_eus-gaap--SharesIssued_iI_pid_c20260226__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zKKG4LFlh5U8" title="Number of units issued during period"&gt;11,197,131&lt;/span&gt;
units (the &#x201c;Units&#x201d; and, with respect to the ordinary shares included in the Units being offered, the &#x201c;Public
Shares&#x201d;) including the partial exercise of the over-allotment option of &lt;span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20260226__20260227__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zi2TkWzHOYHe" title="Number of units issued during period"&gt;1,197,131&lt;/span&gt;
Units granted to the underwriters. Each Unit consists of one ordinary share and one right to receive one-fourth (1/4) of one
ordinary share upon the completion of the initial Business Combination. The Units were sold at an offering price of $&lt;span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20260227__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z4tnKs1ifLGi" title="Offering price"&gt;10.00&lt;/span&gt;
per unit, generating gross proceeds of $&lt;span id="xdx_90B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20260226__20260227__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zDIuZ5qTarF4" title="Gross proceeds"&gt;111,971,310&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the IPO and the sale of the Units, the Company consummated the private placement of &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260226__20260227__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zcWBIXgj6AL" title="Private placement units issued during period"&gt;208,971&lt;/span&gt; units (the &#x201c;Private
Units&#x201d;) to the Sponsor at a price of $&lt;span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_c20260227__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zYMA1DIr0yUh" title="Private placement, price"&gt;10.00&lt;/span&gt; per Private Unit, generating total proceeds of $&lt;span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20260226__20260227__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zIM61I7hXBdd" title="Proceeds from issuance of private placement"&gt;2,089,710&lt;/span&gt;, which is described in Note
4.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 10, 2026, the underwriters notified the Company of their exercise of the remaining balance of the over-allotment option to purchase
an additional &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20260409__20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zoNBZuByn712"&gt;302,869&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Units at a price of $&lt;span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z6lmqZJ6kuJd"&gt;10.00&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Unit. The closing of the over-allotment option occurred
on April 15, 2026, generating additional gross proceeds of $&lt;span id="xdx_906_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20260414__20260415__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zsibSZDFxYIf"&gt;3,028,690&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
Simultaneously with the closing of the over-allotment option, the Company consummated the private placement of an aggregate of &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260409__20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zf0lxRabXRIi"&gt;3,029&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Private Units to the Sponsor, at a price of $&lt;span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zrYXv918XhRk"&gt;10.00&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;per Private Unit, generating gross proceeds of $&lt;span id="xdx_906_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20260409__20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zFNQkZ5Yqeui"&gt;30,290&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
As a result, the Company sold an aggregate of&#160;&lt;span id="xdx_90A_eus-gaap--PartnersCapitalAccountUnitsSoldInPublicOffering_pid_c20260409__20260410_zwQ9KcKEFga4"&gt;11,500,000&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;Public
Units and&#160;&lt;span id="xdx_906_eus-gaap--PartnersCapitalAccountUnitsSoldInPrivatePlacement_pid_c20260409__20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zEiOtd0XXKoj"&gt;212,000&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Private Units.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Transaction
costs amounted to $&lt;span id="xdx_90D_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20260409__20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z2tcnmRCYcS8"&gt;1,582,000&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;consisting of $&lt;span id="xdx_905_eus-gaap--PaymentsForCommissions_c20260409__20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z6uA8JNtC3K6"&gt;1,150,000&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of underwriting commissions which was paid in cash at the closing
date of the IPO and over-allotment, $&lt;span id="xdx_907_eus-gaap--ShareBasedCompensation_c20260409__20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z6z5It2RXyck"&gt;77,800&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;estimated fair value of the Representative Shares (discussed
below), and $&lt;span id="xdx_906_eus-gaap--OtherOwnershipInterestsOfferingCosts_iI_c20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z9GR5G4Y22u3"&gt;354,200&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;of legal and other offering costs. At the IPO date, cash of
$&lt;span id="xdx_90B_eus-gaap--CashAndCashEquivalentsAtCarryingValue_iI_c20260227__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zre9FtVElwsh"&gt;584,080&lt;/span&gt;&lt;/span&gt;
&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;was held outside of the Trust Account (as defined below) and
was available for working capital purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
conjunction with the IPO, the Company issued to the underwriter &lt;span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_pid_c20260227__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zpcdl70CL1ih" title="Ordinary shares, shares issued"&gt;50,000&lt;/span&gt; ordinary shares for no consideration (the &#x201c;Representative
Shares&#x201d;). The fair value of the Representative Shares accounted for as compensation under Accounting Standards Codification (&#x201c;ASC&#x201d;)
718, &#x201c;Compensation &#x2013; Stock Compensation&#x201d; (&#x201c;ASC 718&#x201d;) is included in the offering costs. The estimated fair
value of the Representative Shares as of the IPO date totaled $&lt;span id="xdx_902_eus-gaap--InvestmentsFairValueDisclosure_iI_c20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zhgoUyqN2Vpe" title="Fair value of share-based payment awards"&gt;77,800&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Following
the closing of the IPO on February 27, 2026 and over-allotment option on April 15, 2026, an amount of $&lt;span id="xdx_90D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20260201__20260227__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zLCf46BzdJUc" title="Gross proceeds"&gt;115,000,000&lt;/span&gt; ($&lt;span id="xdx_90E_eus-gaap--SaleOfStockPricePerShare_iI_c20260227__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zB0xSIeMHZ5c" title="Offering price"&gt;10.00&lt;/span&gt; per Unit)
from the net proceeds of the sale of the Units and Private Units in the IPO and over-allotment was placed in a trust account (the &#x201c;Trust
Account&#x201d;), with Continental Stock Transfer &amp;amp; Trust Company acting as trustee. The funds placed in the Trust Account are initially
to be held in cash, including demand deposit accounts at a bank, or invested in U.S. government securities, within the meaning set forth
in Section 2(a)(16) of the Investment Company Act of 1940, with a maturity of 185 days or less, or in money market funds meeting certain
conditions of Rule 2a-7 of the Investment Company Act of 1940 which invest only in direct U.S. government treasury obligations, as determined
by the Company. The proceeds from this offering held in the Trust Account will not be released from the Trust Account (1) to the Company,
until the completion of the initial business combination, or (2) to public shareholders, until the earliest of: (a) the completion of
the initial Business Combination, (b) the redemption of the public shares properly submitted in connection with a shareholder vote to
amend the Company&#x2019;s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company&#x2019;s
obligation to allow redemption in connection with the initial business combination or to redeem 100% of the Company&#x2019;s public shares
if the Company has not consummated an initial business combination within the completion window or (B) with respect to any other material
provisions relating to shareholders&#x2019; rights or pre-initial business combination activity, or (c) the Company&#x2019;s failure to complete an initial Business Combination
within the Combination Period, subject to any valid extension. Interest may also be released to pay taxes as permitted by the trust agreement. The proceeds deposited in the Trust Account
could become subject to the claims of the Company&#x2019;s creditors, if any, which could have priority over the claims of the Company&#x2019;s
public shareholders.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company&#x2019;s initial Business Combination must occur with one or more target businesses that together have an aggregate fair market
value of at least 80% of the balance in the Trust Account (as defined below) (less any taxes payable on interest earned) at the time
of execution of the definitive agreement in connection with its initial Business Combination. However, the Company will only complete
a Business Combination if the post-transaction&#160;company owns or acquires 50% or more of the outstanding voting securities of the
target or otherwise acquires a controlling interest in the target sufficient for the post-transaction&#160;company not to be required
to register as an investment company under the Investment Company Act&#160;of&#160;1940, as amended (the &#x201c;Investment Company Act&#x201d;).
The Company does not believe that its anticipated principal activities will subject the Company to the Investment Company Act. There
is no assurance that the Company will be able to complete a Business Combination successfully.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The ordinary shares subject to redemption are recorded at a redemption value
and classified as temporary equity following completion of the IPO and over-allotment, in accordance with Accounting Standards Codification
(&#x201c;ASC&#x201d;) Topic 480 &#x201c;Distinguishing
Liabilities from Equity.&#x201d; In such case, the Company will proceed with a Business Combination if the Company has net tangible assets
of at least $&lt;span id="xdx_902_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_c20260831_zqYwOhuu2Qx2" title="Net tangible assets required for business combination"&gt;5,000,001&lt;/span&gt; upon such consummation of a Business Combination and, if the Company seeks shareholder approval, it will obtain
the approval of an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a simple majority of the votes cast by shareholders entitled to vote in person
or by proxy at a general meeting of the Company. The Company will have 15 months from the effective date of the registration statement
on Form S-1 to consummate its initial Business Combination (the &#x201c;Combination Period&#x201d;). If the Company anticipates that it
may be unable to consummate the initial Business Combination within 15 months, it may seek shareholder approval to amend its second amended
and restated memorandum and articles of association to extend the deadline (&#x201c;Extension Period&#x201d;) by which it must complete the
initial Business Combination. If the Company is unable to complete the initial Business Combination within the Combination Period, the
Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than
ten business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on
deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company
(less taxes payable and up to $&lt;span id="xdx_903_ecustom--InterestToPayDissolutionExpenses_iI_c20260831_zRD1NIwwvnee" title="Interest to pay dissolution expenses"&gt;100,000&lt;/span&gt; of interest to pay dissolution expenses), divided by the number of then outstanding public shares,
which redemption will completely extinguish public shareholders&#x2019; rights as shareholders (including the right to receive further
liquidating distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of
the Company&#x2019;s remaining shareholders and its board of directors, dissolve and liquidate, subject in each case to the Company&#x2019;s
obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. There will be no
redemption rights or liquidating distributions with respect to the Company&#x2019;s rights, which will expire worthless if the Company
fails to complete the Business Combination within Combination Period or during any extension period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Founder Shares (as defined in Note 5) except as described below, are identical to the ordinary shares included in the units being sold
in this offering, and holders of Founder Shares have the same shareholder rights as public shareholders, except that (a) the Founder
Shares are subject to certain transfer restrictions, as described in more detail below; (b) the Company&#x2019;s initial shareholders
have entered into an agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect
to their Founder Shares and Private Shares in connection with the completion of the initial Business Combination, (ii) waive their redemption
rights with respect to their Founder Shares, Private Shares and Public Shares held by them in connection with a shareholder vote to approve
an amendment to the Company&#x2019;s amended and restated memorandum and articles of association (A) to modify the substance or timing
of the Company&#x2019;s obligation to provide for the redemption of the Company&#x2019;s public shares in connection with an initial business
combination or to redeem 100% of the public shares if the Company has not consummated the Company&#x2019;s initial business combination
within the timeframe set forth therein or (B) with respect to any other provision relating to shareholders&#x2019; rights or pre-initial
business combination activity, and (iii) to waive their rights to liquidating distributions from the Trust Account with respect to their
Founder Shares and Private Shares if the Company fails to complete its initial business combination within 15 months from the effective
date of the registration statement on Form S-1 or during any extension period (although they will be entitled to liquidating distributions
from the Trust Account with respect to any public shares they hold if the Company fails to complete the Company&#x2019;s initial business
combination within the prescribed time frame) and (c) are entitled to certain registration rights to provide for the resale of such shares
under the Securities Act. If the Company submits its initial Business Combination to its public shareholders for a vote, its founder
has agreed (and its permitted transferees will agree) to vote their Founder Shares, Private Shares and any Public Shares purchased during
or after this offering (including in open market and privately-negotiated&#160;transactions, aside from shares they may purchase in compliance
with the requirements of Rule&#160;14e-5&#160;under the Exchange&#160;Act, which would not be voted in favor of approving the business
combination transaction) in favor of its initial Business Combination. The other members of the Company&#x2019;s management team have
entered into agreements similar to the one entered into by the Company&#x2019;s Sponsor with respect to any public shares acquired by
them in or after this offering.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Furthermore, the Sponsor has agreed (A) to vote the ordinary shares underlying
the private units, or &#x201c;private shares,&#x201d; in favor of any proposed business combination, (B) not to propose, or vote in favor
of, an amendment to the Company&#x2019;s post-offering amended and restated memorandum and articles of association that would stop the
Company&#x2019;s public shareholders from converting or selling their shares to the Company in connection with a business combination or
affect the substance or timing of the Company&#x2019;s obligation to redeem 100% of the public shares if the Company does not complete
a business combination within 15 months from the effective date of the registration statement for the IPO, unless the Company provides
public shareholders with the opportunity to redeem their public shares from the trust account in connection with any such vote, (C) not
to convert any private shares for cash from the trust account in connection with a shareholder vote to approve the Company&#x2019;s proposed
initial business combination or a vote to amend the provisions of the Company&#x2019;s post-offering amended and restated memorandum and
articles of association relating to shareholders&#x2019; rights or pre-business combination activity, and (D) that the private shares shall
not participate in any liquidating distribution upon winding up if a business combination is not consummated. The Sponsor has also agreed
not to transfer, assign or sell any of the private units or underlying securities (except to the same permitted transferees as the founder
shares and provided that the transferees agree to the same terms and restrictions as the permitted transferees of the founder shares must
agree to, each as described above) until 30 days after the completion of its initial business combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company&#x2019;s
independent registered public accounting firm) for services rendered or products sold to the Company, or by a prospective target business
with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below
(i) $&lt;span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_c20260831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--TrustAccountMember_zGDBCa50Uduf" title="Price per share"&gt;10.00&lt;/span&gt; per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of
the Trust Account if less than $&lt;span id="xdx_90A_eus-gaap--SharePrice_iI_c20260831_ziC9Y3e365Cl" title="Trust protection threshold"&gt;10.00&lt;/span&gt; per public share due to reductions in the value of the trust assets, in each case net of the interest
which may be withdrawn to pay taxes. This liability will not apply with respect to any claims by a third party or prospective target
business who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company&#x2019;s
indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. Moreover, in the
event that an executed waiver is deemed to be unenforceable against a third party, then the Company&#x2019;s Sponsor will not be responsible
to the extent of any liability for such third-party claims.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Going
Concern Consideration&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of August 31, 2026, the Company had cash of $&lt;span id="xdx_90D_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_iI_c20260831_zWptLI7pKNA4" title="Cash"&gt;1,148&lt;/span&gt; and a working capital deficit of $&lt;span id="xdx_90A_ecustom--WorkingCapitalDeficit_iI_c20260831_zAIuiy0kaM7i" title="Working capital"&gt;338,372&lt;/span&gt;. The Sponsor has agreed to loan the Company
up to $&lt;span id="xdx_901_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20260831_zlk0kLgUOse7" title="Line of credit facility, maximum borrowing capacity for IPO expenses"&gt;500,000&lt;/span&gt; to be used for a portion of the expenses of the IPO. The loan is non-interest bearing, unsecured and shall be payable
promptly after the date on which the Company consummates an initial public offering of its securities or the date on which the Company
determines not to conduct an initial public offering of its securities. The loan was repaid upon the closing of the IPO out of the offering
proceeds not held in the Trust Account.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Subsequent
to the consummation of the IPO, the Company&#x2019;s liquidity has been satisfied through the net proceeds from the IPO and Private Placement.
The Company has incurred and expects to continue to incur significant professional costs to remain as a publicly traded company and to
incur significant transaction costs in pursuit of the consummation of a Business Combination.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company initially has 15 months from the effective date of the registration
statement to consummate the initial Business Combination (assuming no extensions). If the Company does not complete a Business Combination,
the Company will wind up, dissolve and liquidate pursuant to the terms of its second amended and restated memorandum and articles of association.
There is a possibility that the Business Combination may not be consummated within the 15-month period from the effective date of the
registration statement. Management has determined that the mandatory liquidation, should a business combination not occur, and potential
subsequent dissolution, together with the Company&#x2019;s limited liquidity outside the Trust Account, raises substantial doubt about
the Company&#x2019;s ability to continue as a going concern. Management&#x2019;s plans to address this uncertainty consist of completing
the Business Combination with Korai (see Note 9) within the Combination Period or obtaining shareholder approval of an extension, and
obtaining loans from the Sponsor or its affiliates to fund operating costs, none of which is assured. No adjustments have been made to
the carrying amounts of assets or liabilities should the Company be required to liquidate after the Combination Period (assuming no extensions).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Risks
and Uncertainties&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Various
social and political circumstances in the U.S. and around the world (including rising trade tensions between the U.S. and China, and
other uncertainties regarding actual and potential shifts in the U.S. and foreign, trade, economic and other policies with other countries),
may contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
a result of the ongoing global conflicts and/or other future global conflicts, the Company&#x2019;s ability to consummate a Business Combination,
or the operations of a target business with which the Company ultimately consummates a Business Combination, may be materially and adversely
affected. In addition, the Company&#x2019;s ability to consummate a transaction may be dependent on the ability to raise equity and debt
financing which may be impacted by these events, including as a result of increased market volatility, or decreased market liquidity
in third-party financing being unavailable on terms acceptable to the Company or at all. The impact of this action and potential future
sanctions on the world economy and the specific impact on the Company&#x2019;s financial position, results of operations or ability to
consummate a Business Combination are not yet determinable. The financial statements do not include any adjustments that might result
from the outcome of this uncertainty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:SharesIssued
      contextRef="AsOf2026-02-26_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000465"
      unitRef="Shares">11197131</us-gaap:SharesIssued>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2026-02-262026-02-27_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000467"
      unitRef="Shares">1197131</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2026-02-27_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000469"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2026-02-262026-02-27_us-gaap_IPOMember"
      decimals="0"
      id="Fact000471"
      unitRef="USD">111971310</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2026-02-262026-02-27_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000473"
      unitRef="Shares">208971</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2026-02-27_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000475"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2026-02-262026-02-27_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact000477"
      unitRef="USD">2089710</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2026-04-092026-04-10_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000478"
      unitRef="Shares">302869</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2026-04-10_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000479"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2026-04-142026-04-15_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact000480"
      unitRef="USD">3028690</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2026-04-092026-04-10_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000481"
      unitRef="Shares">3029</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2026-04-10_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000482"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2026-04-092026-04-10_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact000483"
      unitRef="USD">30290</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PartnersCapitalAccountUnitsSoldInPublicOffering
      contextRef="From2026-04-092026-04-10"
      decimals="INF"
      id="Fact000484"
      unitRef="Shares">11500000</us-gaap:PartnersCapitalAccountUnitsSoldInPublicOffering>
    <us-gaap:PartnersCapitalAccountUnitsSoldInPrivatePlacement
      contextRef="From2026-04-092026-04-10_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000485"
      unitRef="Shares">212000</us-gaap:PartnersCapitalAccountUnitsSoldInPrivatePlacement>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="From2026-04-092026-04-10_us-gaap_IPOMember"
      decimals="0"
      id="Fact000486"
      unitRef="USD">1582000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsForCommissions
      contextRef="From2026-04-092026-04-10_us-gaap_IPOMember"
      decimals="0"
      id="Fact000487"
      unitRef="USD">1150000</us-gaap:PaymentsForCommissions>
    <us-gaap:ShareBasedCompensation
      contextRef="From2026-04-092026-04-10_us-gaap_IPOMember"
      decimals="0"
      id="Fact000488"
      unitRef="USD">77800</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherOwnershipInterestsOfferingCosts
      contextRef="AsOf2026-04-10_us-gaap_IPOMember"
      decimals="0"
      id="Fact000489"
      unitRef="USD">354200</us-gaap:OtherOwnershipInterestsOfferingCosts>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="AsOf2026-02-27_us-gaap_IPOMember"
      decimals="0"
      id="Fact000490"
      unitRef="USD">584080</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CommonStockSharesIssued
      contextRef="AsOf2026-02-27_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000492"
      unitRef="Shares">50000</us-gaap:CommonStockSharesIssued>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2026-04-10_us-gaap_IPOMember"
      decimals="0"
      id="Fact000494"
      unitRef="USD">77800</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2026-02-012026-02-27_us-gaap_IPOMember"
      decimals="0"
      id="Fact000496"
      unitRef="USD">115000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2026-02-27_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000498"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000500"
      unitRef="USD">5000001</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <TRAD:InterestToPayDissolutionExpenses
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000502"
      unitRef="USD">100000</TRAD:InterestToPayDissolutionExpenses>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2026-08-31_custom_TrustAccountMember"
      decimals="INF"
      id="Fact000504"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SharePrice
      contextRef="AsOf2026-08-31"
      decimals="INF"
      id="Fact000506"
      unitRef="USDPShares">10.00</us-gaap:SharePrice>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000508"
      unitRef="USD">1148</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <TRAD:WorkingCapitalDeficit
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000510"
      unitRef="USD">338372</TRAD:WorkingCapitalDeficit>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000512"
      unitRef="USD">500000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000514">&lt;p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zNo4KkFu8r19" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
2 &#x2014; &lt;span id="xdx_825_zyaljZ5k94D3"&gt;Basis of Presentation and Summary of Significant Accounting Policies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zXAVyGL2kbmk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Basis
of Presentation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements are presented in accordance with accounting principles generally accepted in the United States of America
(&#x201c;U.S. GAAP&#x201d;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_ecustom--EmergingGrowthCompanyStatusPolicyTextBlock_zAV19h6samTb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Emerging
Growth Company Status&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a) of the Securities Act of 1933, as amended, (the
&#x201c;Securities Act&#x201d;), as modified by the Jumpstart Our Business Startups Act of 2012, (the &#x201c;JOBS Act&#x201d;), and it may
take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404
of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements,
and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any
golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out
of such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_844_eus-gaap--UseOfEstimates_z99uJh4irXY7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Use
of Estimates&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z3BEbLaaJE7i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Cash
and Cash Equivalents&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had $&lt;span id="xdx_90A_eus-gaap--Cash_iI_c20260831_zQnWeowodrK7" title="Cash"&gt;1,148&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--Cash_iI_dxL_c20250831_zJONNrpTi82i" title="Cash::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0526"&gt;0&lt;/span&gt;&lt;/span&gt; in cash as of August 31, 2026 and 2025, respectively. The Company did not have cash equivalents for both
periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_ecustom--InvestmentsHeldInTrustAccountPolicyTextBlock_zfNdzzAhEPab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Investments
Held in Trust Account&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
August 31, 2026, substantially all of the assets held in the Trust Account were held in money market funds which are invested primarily
in U.S. Treasury securities. All of the Company&#x2019;s investments held in the Trust Account are classified as trading securities. Trading
securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the
change in fair value of investments held in the Trust Account are included in interest earned on investments held in Trust Account in
the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available
market information. Fair values of these investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active
markets for identical assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zfABOzVyEzLi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Concentration
of Credit Risk&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial instruments that potentially subject the Company to concentrations
of credit risk consist of cash held in an operating account at East West Bank and money market fund investments held in the Trust Account
at J.P. Morgan Securities LLC. As of August 31, 2026, the operating account balance of $&lt;span id="xdx_90A_eus-gaap--Cash_iI_c20260831_zWE2wDPx8gq8" title="Cash"&gt;1,148&lt;/span&gt; was below the standard Federal Deposit Insurance
Corporation (&#x201c;FDIC&#x201d;) insurance limit of $&lt;span id="xdx_908_eus-gaap--CashFDICInsuredAmount_iI_c20260831_zx1y3b7BzCa6" title="Federal deposit insurance corporation amount"&gt;250,000&lt;/span&gt;. As of August 31, 2026, the Trust Account balance of $&lt;span id="xdx_90F_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20260831_zKEAPxeYR7S5" title="Trust Account balance"&gt;116,695,841&lt;/span&gt; exceeded
the standard Securities Investor Protection Corporation (&#x201c;SIPC&#x201d;) protection limit of $&lt;span id="xdx_903_ecustom--CashSIPCInsuredAmount_iI_c20260831_zVxlVXvSvHv8" title="Federal deposit insurance corporation amount"&gt;500,000&lt;/span&gt; by $&lt;span id="xdx_903_eus-gaap--AssetsHeldInTrust_iI_c20260831__dei--LegalEntityAxis__custom--SecuritiesInvestorProtectionCorporationMember_zV2EA2sNmPCg" title="Trust Account balance"&gt;116,195,841&lt;/span&gt;. Any loss incurred
or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition, results of operations,
and cash flows. The Company has not experienced losses on these accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eus-gaap--DeferredChargesPolicyTextBlock_zSi3E6w5OEyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Offering
Costs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with the requirements of FASB ASC Topic 340-10-S99-1, &#x201c;Other Assets and Deferred Costs &#x2013; SEC Materials&#x201d;
(&#x201c;ASC 340-10-S99&#x201d;) and SEC Staff Accounting Bulletin Topic 5A, &#x201c;Expenses of Offering&#x201d;. Deferred offering costs
were $&lt;span id="xdx_90C_eus-gaap--DeferredFinanceCostsGross_iI_c20260831_zB2azTDrL092" title="Deferred offering costs"&gt;1,582,000&lt;/span&gt; consisting of $&lt;span id="xdx_908_eus-gaap--DeferredSalesCommission_iI_c20260831_zVNSZaUvmPXl" title="Underwriting commissions"&gt;1,150,000&lt;/span&gt; underwriting commissions, $&lt;span id="xdx_905_eus-gaap--InvestmentsFairValueDisclosure_iI_c20260831_zQ1pfKx65rw3" title="Estimated fair value"&gt;77,800&lt;/span&gt; estimated fair value of the Representative Shares and $&lt;span id="xdx_906_eus-gaap--OtherOwnershipInterestsOfferingCosts_iI_c20260831_zRa1c80Qyul4" title="Legal and other offering expenses"&gt;354,200&lt;/span&gt;
legal and other offering expenses that are directly related to the IPO . Upon completion of the IPO, $&lt;span id="xdx_907_ecustom--PublicSharesIssuanceCosts_c20250901__20260831_zFNq1F0MDNA3" title="Public shares issuance costs"&gt;1,542,450&lt;/span&gt; was allocated to ordinary shares
subject to possible redemption and $&lt;span id="xdx_907_ecustom--PublicSharesIssuanceCostAllocatedToEquity_c20250901__20260831_zfEKsQ2bk8Ag" title="Public shares issuance cost allocated to equity"&gt;39,550&lt;/span&gt; was allocated to the Public Rights and charged to shareholders&#x2019; equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z9BpgYHpQMU2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair
Value of Financial Instruments&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under FASB ASC 820, &#x201c;Fair Value
Measurements and Disclosures,&#x201d; approximates the carrying amounts represented in the balance sheet, primarily due to its short-term
nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that
framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a
liability in the Company&#x2019;s principal or most advantageous market in an orderly transaction between market participants on the measurement
date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize
the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use
in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable
inputs reflect the entity&#x2019;s own assumptions based on market data and the entity&#x2019;s judgments about the assumptions that market
participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1&#x2014;Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement
are observable inputs, such as quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2&#x2014;Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying
terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted
intervals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3&#x2014;Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little
or no market data exists for the assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_z9noaFKL4x29" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary
Shares Subject to Possible Redemption&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company accounts for ordinary shares subject to possible redemption
in accordance with the guidance in ASC 480. Ordinary shares subject to mandatory redemption (if any) are classified as liability instruments
and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that
are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s
control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders&#x2019; equity. Ordinary
shares feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to the occurrence
of uncertain future events.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In accordance with the SEC and its guidance on redeemable equity instruments,
which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a company require ordinary shares subject
to redemption to be classified outside of permanent equity. Given that the 11,500,000 ordinary shares sold as part of the Company&#x2019;s
IPO were issued with other freestanding instruments (i.e., Public Rights), the initial carrying value of ordinary shares classified as
temporary equity has been allocated to the proceeds determined in accordance with ASC 470-20. The Company&#x2019;s ordinary shares&#160;are
subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i)
accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the
instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption
value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting
period. The Company has elected to recognize the changes immediately. The initial accretion and subsequent remeasurements will be treated
as a deemed dividend (i.e., a reduction to additional paid-in capital and, to the extent additional paid-in capital
is exhausted, accumulated deficit). Accordingly, as of August 31, 2026, ordinary shares subject to possible
redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; equity section of the Company&#x2019;s
balance sheet. As of August 31, 2026, the ordinary shares subject to redemption reflected in the balance sheet are reconciled in the following
table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--TemporaryEquityTableTextBlock_ztwLFiwfZnXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zU7G2yVAYoig"&gt;Schedule
of Ordinary Shares Subject to Possible Redemption Reflected in the Unaudited Condensed Balance Sheets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20250901__20260831_zjRvGNojGy9g" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_zhky7Ciddmx1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 84%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross proceeds&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;115,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--TemporaryEquityProceedsAllocatedToPublicShareRights_iN_di_zFHkYuFb6TSj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds allocated to public share rights&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,875,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--TemporaryEquityPublicSharesIssuanceCosts_iN_di_zC1nEaDyiPph" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Public shares issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,542,450&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--AccretionOfCarryingValueOfRedemptionsValue_zg6nTxpphe43" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accretion of carrying value of redemption value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,417,450&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_zQjjfWiuFXml" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subsequent remeasurement
    of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,695,841&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zAeS59TP40F1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ordinary shares subject to possible redemption
    as of August 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,695,841&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zm13QBWAxgBh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zsOR6dN6D3pc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net
Income (Loss) Per Ordinary Share&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include
a presentation of net income per redeemable share and net income per non-redeemable share following the two-class method of net income
per share because redemption of the redeemable shares is not at fair value pursuant to the guidance in ASC 480-10-S99. Net income per
ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period. The
Company has elected to treat only the portion of the periodic adjustment to the carrying amount of the redeemable shares that reflects
a redemption in excess of fair value like a dividend. As such, income or loss allocable to each class of ordinary share is not adjusted
for the accretion of carrying value to redemption value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of diluted net income per ordinary share does not consider the effect of the rights issued in connection with the IPO and
the Private Units since the exercise of the rights is contingent upon the occurrence of future events. As of August 31, 2026 and 2025,
the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary
shares that then share in the earnings of the Company.&#160;As a result, diluted net income per ordinary share is the same as basic net
income per ordinary share for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zbeS5iIXLAml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
net income per share presented in the statements of operations is based on the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zGrw3V7ORYgh"&gt;Schedule
of Basic and Diluted Net Income Per Ordinary Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20250901__20260831_zuZ6UxsxKim2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
                                            the&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ended
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;August
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20250829__20250831_zB1foKXQ3sMh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;from&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August
                                            29, 2025&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Inception)&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;through&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August
                                            31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLoss_zZzRSjdHWDd7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net income
    (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;733,717&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17,047&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zaFz5eEAzfN1" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zIRY26FNIpB1" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zbgbJdOQTcj5" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zGDeJF37hEWc" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
                                            the Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ended
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;August
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Period from&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August
                                            29, 2025&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Inception)
                                            through&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August
                                            31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--NetIncomeLoss_zq9iPMyZeV15" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 32%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allocation
    of net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;482,888&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,829&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0583"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17,047&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares
    outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_z6VpLCt6XKYb" title="Basic weighted average shares outstanding"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zgCAXMJayA42" title="Diluted weighted average shares outstanding"&gt;5,789,768&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_z7eMPfrvMvf7" title="Diluted weighted average shares outstanding"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zeOIkZE0txIe" title="Basic weighted average shares outstanding"&gt;3,007,404&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_z4PIesxggcTc" title="Basic weighted average shares outstanding"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zpHTuCihpSlh" title="Diluted weighted average shares outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0594"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0596"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zUX7LGOm5AO2" title="Basic weighted average shares outstanding"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zoDY4wE34Ns" title="Diluted weighted average shares outstanding"&gt;2,500,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net
    income (loss) per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zgAP2Ud3Ezbl" title="Basic net income (loss) per ordinary share"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zlkMMLYl93Y8" title="Diluted net income (loss) per ordinary share"&gt;0.08&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareBasic_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zPRjdnKFV2Z9" title="Basic net income (loss) per ordinary share"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zhUqxBGNfct7" title="Diluted net income (loss) per ordinary share"&gt;0.08&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zvvu0a1aKDJ4" title="Basic net income (loss) per ordinary share"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zS5fiv1zRHWl" title="Diluted net income (loss) per ordinary share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0610"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0612"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zaLbXqE6c1P9" title="Basic net income (loss) per ordinary share"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zkLgTB2UYfDa" title="Diluted net income (loss) per ordinary share"&gt;(0.01&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zyVE3tnpUHLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_843_ecustom--RightsAccountingPolicyTextBlock_zlASGhngYsyd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Rights
Accounting&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for rights as either equity-classified or liability-classified instrument based on an assessment of the right&#x2019;s
specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the rights are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the rights meet all of
the requirements for equity classification under ASC 815, including whether the rights are indexed to the Company&#x2019;s own ordinary
shares and whether the right holders could potentially require &#x201c;net cash settlement&#x201d; in a circumstance outside of the Company&#x2019;s
control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted
at the time of right issuance and as of each subsequent quarterly period end date while the rights are outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
issued or modified rights that meet all of the criteria for equity classification, the rights are required to be recorded as a component
of equity at the time of issuance. For issued or modified rights that do not meet all the criteria for equity classification, the rights
are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of the rights are recognized as a non-cash gain or loss on the statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
the rights to be issued upon the closing of the IPO and sale of Private Units meet the criteria for equity classification under ASC 815,
therefore, the rights are classified as equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_zO7yES2cx532" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Income
Taxes&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes under ASC 740 Income Taxes (&#x201c;ASC 740&#x201d;). ASC 740 requires the recognition of deferred tax
assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities
and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation
allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim
period, disclosure and transition. Based on the Company&#x2019;s evaluation, it has been concluded that there are no significant uncertain
tax positions requiring recognition in the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized
tax benefits and no amounts accrued for interest and penalties as of August 31, 2026 and 2025. The Company is currently not aware of
any issues under review that could result in significant payments, accruals or material deviation from its position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is considered to be an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements
in the Cayman Islands or the United States. Under current Cayman Islands law, income taxes are not levied on the Company. Consequently,
income taxes are not reflected in the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ztoyFcwZGpHl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Recent
Accounting Pronouncements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07, &#x201c;Segment Reporting (Topic 280): Improvements
to Reportable Segment Disclosures.&#x201d; The amendments in this ASU require disclosures, on an annual and interim basis, of significant
segment expenses that are regularly provided to the chief operating decision maker (&#x201c;CODM&#x201d;), as well as the aggregate amount
of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the
title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing
segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently
required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required
by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December
15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted
ASU 2023-07 on August 29, 2025, date of incorporation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December&#160;2023, the FASB issued Accounting Standards Update 2023-09, &#x201c;Income Taxes (Topic 740): Improvements to Income Tax
Disclosure&#x201d; (&#x201c;ASU 2023-09&#x201d;). ASU 2023-09 mostly requires, on an annual basis, disclosure of specific categories in
an entity&#x2019;s effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. The incremental disclosures
may be presented on a prospective or retrospective basis. The ASU is effective for fiscal years beginning after December&#160;15, 2024
with early adoption permitted. The Company adopted the ASU 2023-09 on September 1, 2025, the beginning of its fiscal year. As a Cayman Island entity, the Company is not
subject to income taxes, as such, the Company did not have any material impact of adopting ASU 2023-09 on its financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a
material effect on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85D_zfidgTvhPMRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000516">&lt;p id="xdx_84E_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zXAVyGL2kbmk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Basis
of Presentation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
accompanying financial statements are presented in accordance with accounting principles generally accepted in the United States of America
(&#x201c;U.S. GAAP&#x201d;) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (&#x201c;SEC&#x201d;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <TRAD:EmergingGrowthCompanyStatusPolicyTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000518">&lt;p id="xdx_84F_ecustom--EmergingGrowthCompanyStatusPolicyTextBlock_zAV19h6samTb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Emerging
Growth Company Status&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a) of the Securities Act of 1933, as amended, (the
&#x201c;Securities Act&#x201d;), as modified by the Jumpstart Our Business Startups Act of 2012, (the &#x201c;JOBS Act&#x201d;), and it may
take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging
growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404
of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements,
and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any
golden parachute payments not previously approved.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Further,
Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial
accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective
or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out
of such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</TRAD:EmergingGrowthCompanyStatusPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="From2025-09-01to2026-08-31" id="Fact000520">&lt;p id="xdx_844_eus-gaap--UseOfEstimates_z99uJh4irXY7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Use
of Estimates&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the
reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements
and the reported amounts of expenses during the reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating
its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ
significantly from those estimates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000522">&lt;p id="xdx_846_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_z3BEbLaaJE7i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Cash
and Cash Equivalents&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had $&lt;span id="xdx_90A_eus-gaap--Cash_iI_c20260831_zQnWeowodrK7" title="Cash"&gt;1,148&lt;/span&gt; and $&lt;span id="xdx_901_eus-gaap--Cash_iI_dxL_c20250831_zJONNrpTi82i" title="Cash::XDX::-"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0526"&gt;0&lt;/span&gt;&lt;/span&gt; in cash as of August 31, 2026 and 2025, respectively. The Company did not have cash equivalents for both
periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:Cash
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000524"
      unitRef="USD">1148</us-gaap:Cash>
    <TRAD:InvestmentsHeldInTrustAccountPolicyTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000528">&lt;p id="xdx_84D_ecustom--InvestmentsHeldInTrustAccountPolicyTextBlock_zfNdzzAhEPab" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Investments
Held in Trust Account&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;At
August 31, 2026, substantially all of the assets held in the Trust Account were held in money market funds which are invested primarily
in U.S. Treasury securities. All of the Company&#x2019;s investments held in the Trust Account are classified as trading securities. Trading
securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the
change in fair value of investments held in the Trust Account are included in interest earned on investments held in Trust Account in
the accompanying statements of operations. The estimated fair values of investments held in Trust Account are determined using available
market information. Fair values of these investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active
markets for identical assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</TRAD:InvestmentsHeldInTrustAccountPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="From2025-09-01to2026-08-31" id="Fact000530">&lt;p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zfABOzVyEzLi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Concentration
of Credit Risk&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Financial instruments that potentially subject the Company to concentrations
of credit risk consist of cash held in an operating account at East West Bank and money market fund investments held in the Trust Account
at J.P. Morgan Securities LLC. As of August 31, 2026, the operating account balance of $&lt;span id="xdx_90A_eus-gaap--Cash_iI_c20260831_zWE2wDPx8gq8" title="Cash"&gt;1,148&lt;/span&gt; was below the standard Federal Deposit Insurance
Corporation (&#x201c;FDIC&#x201d;) insurance limit of $&lt;span id="xdx_908_eus-gaap--CashFDICInsuredAmount_iI_c20260831_zx1y3b7BzCa6" title="Federal deposit insurance corporation amount"&gt;250,000&lt;/span&gt;. As of August 31, 2026, the Trust Account balance of $&lt;span id="xdx_90F_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20260831_zKEAPxeYR7S5" title="Trust Account balance"&gt;116,695,841&lt;/span&gt; exceeded
the standard Securities Investor Protection Corporation (&#x201c;SIPC&#x201d;) protection limit of $&lt;span id="xdx_903_ecustom--CashSIPCInsuredAmount_iI_c20260831_zVxlVXvSvHv8" title="Federal deposit insurance corporation amount"&gt;500,000&lt;/span&gt; by $&lt;span id="xdx_903_eus-gaap--AssetsHeldInTrust_iI_c20260831__dei--LegalEntityAxis__custom--SecuritiesInvestorProtectionCorporationMember_zV2EA2sNmPCg" title="Trust Account balance"&gt;116,195,841&lt;/span&gt;. Any loss incurred
or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition, results of operations,
and cash flows. The Company has not experienced losses on these accounts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:Cash
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000532"
      unitRef="USD">1148</us-gaap:Cash>
    <us-gaap:CashFDICInsuredAmount
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000534"
      unitRef="USD">250000</us-gaap:CashFDICInsuredAmount>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000536"
      unitRef="USD">116695841</us-gaap:AssetsHeldInTrustNoncurrent>
    <TRAD:CashSIPCInsuredAmount
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000538"
      unitRef="USD">500000</TRAD:CashSIPCInsuredAmount>
    <us-gaap:AssetsHeldInTrust
      contextRef="AsOf2026-08-31_custom_SecuritiesInvestorProtectionCorporationMember"
      decimals="0"
      id="Fact000540"
      unitRef="USD">116195841</us-gaap:AssetsHeldInTrust>
    <us-gaap:DeferredChargesPolicyTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000542">&lt;p id="xdx_847_eus-gaap--DeferredChargesPolicyTextBlock_zSi3E6w5OEyg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Offering
Costs&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with the requirements of FASB ASC Topic 340-10-S99-1, &#x201c;Other Assets and Deferred Costs &#x2013; SEC Materials&#x201d;
(&#x201c;ASC 340-10-S99&#x201d;) and SEC Staff Accounting Bulletin Topic 5A, &#x201c;Expenses of Offering&#x201d;. Deferred offering costs
were $&lt;span id="xdx_90C_eus-gaap--DeferredFinanceCostsGross_iI_c20260831_zB2azTDrL092" title="Deferred offering costs"&gt;1,582,000&lt;/span&gt; consisting of $&lt;span id="xdx_908_eus-gaap--DeferredSalesCommission_iI_c20260831_zVNSZaUvmPXl" title="Underwriting commissions"&gt;1,150,000&lt;/span&gt; underwriting commissions, $&lt;span id="xdx_905_eus-gaap--InvestmentsFairValueDisclosure_iI_c20260831_zQ1pfKx65rw3" title="Estimated fair value"&gt;77,800&lt;/span&gt; estimated fair value of the Representative Shares and $&lt;span id="xdx_906_eus-gaap--OtherOwnershipInterestsOfferingCosts_iI_c20260831_zRa1c80Qyul4" title="Legal and other offering expenses"&gt;354,200&lt;/span&gt;
legal and other offering expenses that are directly related to the IPO . Upon completion of the IPO, $&lt;span id="xdx_907_ecustom--PublicSharesIssuanceCosts_c20250901__20260831_zFNq1F0MDNA3" title="Public shares issuance costs"&gt;1,542,450&lt;/span&gt; was allocated to ordinary shares
subject to possible redemption and $&lt;span id="xdx_907_ecustom--PublicSharesIssuanceCostAllocatedToEquity_c20250901__20260831_zfEKsQ2bk8Ag" title="Public shares issuance cost allocated to equity"&gt;39,550&lt;/span&gt; was allocated to the Public Rights and charged to shareholders&#x2019; equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:DeferredFinanceCostsGross
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000544"
      unitRef="USD">1582000</us-gaap:DeferredFinanceCostsGross>
    <us-gaap:DeferredSalesCommission
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000546"
      unitRef="USD">1150000</us-gaap:DeferredSalesCommission>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000548"
      unitRef="USD">77800</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:OtherOwnershipInterestsOfferingCosts
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000550"
      unitRef="USD">354200</us-gaap:OtherOwnershipInterestsOfferingCosts>
    <TRAD:PublicSharesIssuanceCosts
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000552"
      unitRef="USD">1542450</TRAD:PublicSharesIssuanceCosts>
    <TRAD:PublicSharesIssuanceCostAllocatedToEquity
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000554"
      unitRef="USD">39550</TRAD:PublicSharesIssuanceCostAllocatedToEquity>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="From2025-09-01to2026-08-31" id="Fact000556">&lt;p id="xdx_84E_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z9BpgYHpQMU2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fair
Value of Financial Instruments&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under FASB ASC 820, &#x201c;Fair Value
Measurements and Disclosures,&#x201d; approximates the carrying amounts represented in the balance sheet, primarily due to its short-term
nature.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company applies ASC 820, which establishes a framework for measuring fair value and clarifies the definition of fair value within that
framework. ASC 820 defines fair value as an exit price, which is the price that would be received for an asset or paid to transfer a
liability in the Company&#x2019;s principal or most advantageous market in an orderly transaction between market participants on the measurement
date. The fair value hierarchy established in ASC 820 generally requires an entity to maximize the use of observable inputs and minimize
the use of unobservable inputs when measuring fair value. Observable inputs reflect the assumptions that market participants would use
in pricing the asset or liability and are developed based on market data obtained from sources independent of the reporting entity. Unobservable
inputs reflect the entity&#x2019;s own assumptions based on market data and the entity&#x2019;s judgments about the assumptions that market
participants would use in pricing the asset or liability and are to be developed based on the best information available in the circumstances.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
1&#x2014;Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement
are observable inputs, such as quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
2&#x2014;Inputs to the fair value measurement are determined using prices for recently traded assets and liabilities with similar underlying
terms, as well as direct or indirect observable inputs, such as interest rates and yield curves that are observable at commonly quoted
intervals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Level
3&#x2014;Inputs to the fair value measurement are unobservable inputs, such as estimates, assumptions, and valuation techniques when little
or no market data exists for the assets or liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000558">&lt;p id="xdx_84A_eus-gaap--SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock_z9noaFKL4x29" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary
Shares Subject to Possible Redemption&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The Company accounts for ordinary shares subject to possible redemption
in accordance with the guidance in ASC 480. Ordinary shares subject to mandatory redemption (if any) are classified as liability instruments
and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that
are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s
control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders&#x2019; equity. Ordinary
shares feature certain redemption rights that are considered to be outside of the Company&#x2019;s control and subject to the occurrence
of uncertain future events.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In accordance with the SEC and its guidance on redeemable equity instruments,
which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of a company require ordinary shares subject
to redemption to be classified outside of permanent equity. Given that the 11,500,000 ordinary shares sold as part of the Company&#x2019;s
IPO were issued with other freestanding instruments (i.e., Public Rights), the initial carrying value of ordinary shares classified as
temporary equity has been allocated to the proceeds determined in accordance with ASC 470-20. The Company&#x2019;s ordinary shares&#160;are
subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either (i)
accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the
instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the redemption
value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting
period. The Company has elected to recognize the changes immediately. The initial accretion and subsequent remeasurements will be treated
as a deemed dividend (i.e., a reduction to additional paid-in capital and, to the extent additional paid-in capital
is exhausted, accumulated deficit). Accordingly, as of August 31, 2026, ordinary shares subject to possible
redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; equity section of the Company&#x2019;s
balance sheet. As of August 31, 2026, the ordinary shares subject to redemption reflected in the balance sheet are reconciled in the following
table:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_eus-gaap--TemporaryEquityTableTextBlock_ztwLFiwfZnXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zU7G2yVAYoig"&gt;Schedule
of Ordinary Shares Subject to Possible Redemption Reflected in the Unaudited Condensed Balance Sheets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20250901__20260831_zjRvGNojGy9g" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_zhky7Ciddmx1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 84%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross proceeds&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;115,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--TemporaryEquityProceedsAllocatedToPublicShareRights_iN_di_zFHkYuFb6TSj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds allocated to public share rights&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,875,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--TemporaryEquityPublicSharesIssuanceCosts_iN_di_zC1nEaDyiPph" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Public shares issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,542,450&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--AccretionOfCarryingValueOfRedemptionsValue_zg6nTxpphe43" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accretion of carrying value of redemption value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,417,450&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_zQjjfWiuFXml" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subsequent remeasurement
    of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,695,841&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zAeS59TP40F1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ordinary shares subject to possible redemption
    as of August 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,695,841&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AF_zm13QBWAxgBh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000560">&lt;p id="xdx_892_eus-gaap--TemporaryEquityTableTextBlock_ztwLFiwfZnXk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B5_zU7G2yVAYoig"&gt;Schedule
of Ordinary Shares Subject to Possible Redemption Reflected in the Unaudited Condensed Balance Sheets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_49D_20250901__20260831_zjRvGNojGy9g" style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_zhky7Ciddmx1" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 84%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Gross proceeds&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;115,000,000&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--TemporaryEquityProceedsAllocatedToPublicShareRights_iN_di_zFHkYuFb6TSj" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Proceeds allocated to public share rights&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(2,875,000&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--TemporaryEquityPublicSharesIssuanceCosts_iN_di_zC1nEaDyiPph" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Public shares issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(1,542,450&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Plus:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--AccretionOfCarryingValueOfRedemptionsValue_zg6nTxpphe43" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Accretion of carrying value of redemption value&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;4,417,450&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_zQjjfWiuFXml" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Subsequent remeasurement
    of carrying value to redemption value&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,695,841&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_iE_zAeS59TP40F1" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Ordinary shares subject to possible redemption
    as of August 31, 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,695,841&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000562"
      unitRef="USD">115000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <TRAD:TemporaryEquityProceedsAllocatedToPublicShareRights
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000564"
      unitRef="USD">2875000</TRAD:TemporaryEquityProceedsAllocatedToPublicShareRights>
    <TRAD:TemporaryEquityPublicSharesIssuanceCosts
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000566"
      unitRef="USD">1542450</TRAD:TemporaryEquityPublicSharesIssuanceCosts>
    <TRAD:AccretionOfCarryingValueOfRedemptionsValue
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000568"
      unitRef="USD">4417450</TRAD:AccretionOfCarryingValueOfRedemptionsValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000570"
      unitRef="USD">1695841</us-gaap:TemporaryEquityAccretionToRedemptionValueAdjustment>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="AsOf2026-08-31"
      decimals="0"
      id="Fact000572"
      unitRef="USD">116695841</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000574">&lt;p id="xdx_849_eus-gaap--EarningsPerSharePolicyTextBlock_zsOR6dN6D3pc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Net
Income (Loss) Per Ordinary Share&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company complies with accounting and disclosure requirements of FASB ASC 260, Earnings Per Share. The statements of operations include
a presentation of net income per redeemable share and net income per non-redeemable share following the two-class method of net income
per share because redemption of the redeemable shares is not at fair value pursuant to the guidance in ASC 480-10-S99. Net income per
ordinary share is computed by dividing net income by the weighted average number of ordinary shares outstanding during the period. The
Company has elected to treat only the portion of the periodic adjustment to the carrying amount of the redeemable shares that reflects
a redemption in excess of fair value like a dividend. As such, income or loss allocable to each class of ordinary share is not adjusted
for the accretion of carrying value to redemption value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
calculation of diluted net income per ordinary share does not consider the effect of the rights issued in connection with the IPO and
the Private Units since the exercise of the rights is contingent upon the occurrence of future events. As of August 31, 2026 and 2025,
the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary
shares that then share in the earnings of the Company.&#160;As a result, diluted net income per ordinary share is the same as basic net
income per ordinary share for the periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zbeS5iIXLAml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
net income per share presented in the statements of operations is based on the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zGrw3V7ORYgh"&gt;Schedule
of Basic and Diluted Net Income Per Ordinary Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20250901__20260831_zuZ6UxsxKim2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
                                            the&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ended
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;August
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20250829__20250831_zB1foKXQ3sMh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;from&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August
                                            29, 2025&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Inception)&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;through&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August
                                            31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLoss_zZzRSjdHWDd7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net income
    (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;733,717&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17,047&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zaFz5eEAzfN1" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zIRY26FNIpB1" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zbgbJdOQTcj5" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zGDeJF37hEWc" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
                                            the Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ended
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;August
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Period from&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August
                                            29, 2025&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Inception)
                                            through&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August
                                            31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--NetIncomeLoss_zq9iPMyZeV15" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 32%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allocation
    of net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;482,888&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,829&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0583"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17,047&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares
    outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_z6VpLCt6XKYb" title="Basic weighted average shares outstanding"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zgCAXMJayA42" title="Diluted weighted average shares outstanding"&gt;5,789,768&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_z7eMPfrvMvf7" title="Diluted weighted average shares outstanding"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zeOIkZE0txIe" title="Basic weighted average shares outstanding"&gt;3,007,404&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_z4PIesxggcTc" title="Basic weighted average shares outstanding"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zpHTuCihpSlh" title="Diluted weighted average shares outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0594"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0596"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zUX7LGOm5AO2" title="Basic weighted average shares outstanding"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zoDY4wE34Ns" title="Diluted weighted average shares outstanding"&gt;2,500,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net
    income (loss) per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zgAP2Ud3Ezbl" title="Basic net income (loss) per ordinary share"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zlkMMLYl93Y8" title="Diluted net income (loss) per ordinary share"&gt;0.08&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareBasic_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zPRjdnKFV2Z9" title="Basic net income (loss) per ordinary share"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zhUqxBGNfct7" title="Diluted net income (loss) per ordinary share"&gt;0.08&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zvvu0a1aKDJ4" title="Basic net income (loss) per ordinary share"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zS5fiv1zRHWl" title="Diluted net income (loss) per ordinary share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0610"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0612"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zaLbXqE6c1P9" title="Basic net income (loss) per ordinary share"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zkLgTB2UYfDa" title="Diluted net income (loss) per ordinary share"&gt;(0.01&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zyVE3tnpUHLj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000576">&lt;p id="xdx_894_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zbeS5iIXLAml" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
net income per share presented in the statements of operations is based on the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8B9_zGrw3V7ORYgh"&gt;Schedule
of Basic and Diluted Net Income Per Ordinary Share&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20250901__20260831_zuZ6UxsxKim2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
                                            the&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ended
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;August
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_492_20250829__20250831_zB1foKXQ3sMh" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;from&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August
                                            29, 2025&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Inception)&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;through&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August
                                            31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eus-gaap--NetIncomeLoss_zZzRSjdHWDd7" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Net income
    (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;733,717&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17,047&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49A_20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zaFz5eEAzfN1" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zIRY26FNIpB1" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_497_20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zbgbJdOQTcj5" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_495_20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zGDeJF37hEWc" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
                                            the Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
                                                                               &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ended
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;August
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the Period from&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August
                                            29, 2025&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Inception)
                                            through&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August
                                            31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Non-redeemable
                                            &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Ordinary&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net income per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eus-gaap--NetIncomeLoss_zq9iPMyZeV15" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 32%; text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Allocation
    of net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;482,888&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;250,829&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0583"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; width: 13%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(17,047&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted weighted average shares
    outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_z6VpLCt6XKYb" title="Basic weighted average shares outstanding"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zgCAXMJayA42" title="Diluted weighted average shares outstanding"&gt;5,789,768&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_z7eMPfrvMvf7" title="Diluted weighted average shares outstanding"&gt;&lt;span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zeOIkZE0txIe" title="Basic weighted average shares outstanding"&gt;3,007,404&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_908_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_z4PIesxggcTc" title="Basic weighted average shares outstanding"&gt;&lt;span id="xdx_90A_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zpHTuCihpSlh" title="Diluted weighted average shares outstanding"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0594"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0596"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_900_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zUX7LGOm5AO2" title="Basic weighted average shares outstanding"&gt;&lt;span id="xdx_90D_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zoDY4wE34Ns" title="Diluted weighted average shares outstanding"&gt;2,500,000&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Basic and diluted net
    income (loss) per ordinary share&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_90B_eus-gaap--EarningsPerShareBasic_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zgAP2Ud3Ezbl" title="Basic net income (loss) per ordinary share"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zlkMMLYl93Y8" title="Diluted net income (loss) per ordinary share"&gt;0.08&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_906_eus-gaap--EarningsPerShareBasic_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zPRjdnKFV2Z9" title="Basic net income (loss) per ordinary share"&gt;&lt;span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_c20250901__20260831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zhUqxBGNfct7" title="Diluted net income (loss) per ordinary share"&gt;0.08&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zvvu0a1aKDJ4" title="Basic net income (loss) per ordinary share"&gt;&lt;span id="xdx_909_eus-gaap--EarningsPerShareDiluted_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinarySharesMember_zS5fiv1zRHWl" title="Diluted net income (loss) per ordinary share"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0610"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0612"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.5pt double; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom: Black 2.5pt double; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span id="xdx_905_eus-gaap--EarningsPerShareBasic_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zaLbXqE6c1P9" title="Basic net income (loss) per ordinary share"&gt;&lt;span id="xdx_908_eus-gaap--EarningsPerShareDiluted_c20250829__20250831__us-gaap--StatementClassOfStockAxis__custom--NonRedeemableOrdinaryShareMember_zkLgTB2UYfDa" title="Diluted net income (loss) per ordinary share"&gt;(0.01&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000578"
      unitRef="USD">733717</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-08-292025-08-31"
      decimals="0"
      id="Fact000579"
      unitRef="USD">-17047</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-09-012026-08-31_custom_RedeemableOrdinarySharesMember"
      decimals="0"
      id="Fact000581"
      unitRef="USD">482888</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-09-012026-08-31_custom_NonRedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000582"
      unitRef="USD">250829</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-08-292025-08-31_custom_NonRedeemableOrdinaryShareMember"
      decimals="0"
      id="Fact000584"
      unitRef="USD">-17047</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-09-012026-08-31_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000586"
      unitRef="Shares">5789768</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-09-012026-08-31_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000588"
      unitRef="Shares">5789768</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-09-012026-08-31_custom_NonRedeemableOrdinaryShareMember"
      decimals="INF"
      id="Fact000590"
      unitRef="Shares">3007404</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-09-012026-08-31_custom_NonRedeemableOrdinaryShareMember"
      decimals="INF"
      id="Fact000592"
      unitRef="Shares">3007404</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="From2025-08-292025-08-31_custom_NonRedeemableOrdinaryShareMember"
      decimals="INF"
      id="Fact000598"
      unitRef="Shares">2500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="From2025-08-292025-08-31_custom_NonRedeemableOrdinaryShareMember"
      decimals="INF"
      id="Fact000600"
      unitRef="Shares">2500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-09-012026-08-31_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000602"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-09-012026-08-31_custom_RedeemableOrdinarySharesMember"
      decimals="INF"
      id="Fact000604"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-09-012026-08-31_custom_NonRedeemableOrdinaryShareMember"
      decimals="INF"
      id="Fact000606"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-09-012026-08-31_custom_NonRedeemableOrdinaryShareMember"
      decimals="INF"
      id="Fact000608"
      unitRef="USDPShares">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="From2025-08-292025-08-31_custom_NonRedeemableOrdinaryShareMember"
      decimals="INF"
      id="Fact000614"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="From2025-08-292025-08-31_custom_NonRedeemableOrdinaryShareMember"
      decimals="INF"
      id="Fact000616"
      unitRef="USDPShares">-0.01</us-gaap:EarningsPerShareDiluted>
    <TRAD:RightsAccountingPolicyTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000618">&lt;p id="xdx_843_ecustom--RightsAccountingPolicyTextBlock_zlASGhngYsyd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Rights
Accounting&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for rights as either equity-classified or liability-classified instrument based on an assessment of the right&#x2019;s
specific terms and applicable authoritative guidance in ASC 480 and ASC 815. The assessment considers whether the rights are freestanding
financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the rights meet all of
the requirements for equity classification under ASC 815, including whether the rights are indexed to the Company&#x2019;s own ordinary
shares and whether the right holders could potentially require &#x201c;net cash settlement&#x201d; in a circumstance outside of the Company&#x2019;s
control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted
at the time of right issuance and as of each subsequent quarterly period end date while the rights are outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For
issued or modified rights that meet all of the criteria for equity classification, the rights are required to be recorded as a component
of equity at the time of issuance. For issued or modified rights that do not meet all the criteria for equity classification, the rights
are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of the rights are recognized as a non-cash gain or loss on the statements of operations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
the rights to be issued upon the closing of the IPO and sale of Private Units meet the criteria for equity classification under ASC 815,
therefore, the rights are classified as equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

</TRAD:RightsAccountingPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000620">&lt;p id="xdx_84D_eus-gaap--IncomeTaxPolicyTextBlock_zO7yES2cx532" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Income
Taxes&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company accounts for income taxes under ASC 740 Income Taxes (&#x201c;ASC 740&#x201d;). ASC 740 requires the recognition of deferred tax
assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities
and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation
allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise&#x2019;s financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim
period, disclosure and transition. Based on the Company&#x2019;s evaluation, it has been concluded that there are no significant uncertain
tax positions requiring recognition in the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized
tax benefits and no amounts accrued for interest and penalties as of August 31, 2026 and 2025. The Company is currently not aware of
any issues under review that could result in significant payments, accruals or material deviation from its position.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is considered to be an exempted Cayman Islands company and is presently not subject to income taxes or income tax filing requirements
in the Cayman Islands or the United States. Under current Cayman Islands law, income taxes are not levied on the Company. Consequently,
income taxes are not reflected in the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000622">&lt;p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_ztoyFcwZGpHl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Recent
Accounting Pronouncements&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
November 2023, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) 2023-07, &#x201c;Segment Reporting (Topic 280): Improvements
to Reportable Segment Disclosures.&#x201d; The amendments in this ASU require disclosures, on an annual and interim basis, of significant
segment expenses that are regularly provided to the chief operating decision maker (&#x201c;CODM&#x201d;), as well as the aggregate amount
of other segment items included in the reported measure of segment profit or loss. The ASU requires that a public entity disclose the
title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing
segment performance and deciding how to allocate resources. Public entities will be required to provide all annual disclosures currently
required by Topic 280 in interim periods, and entities with a single reportable segment are required to provide all the disclosures required
by the amendments in this ASU and existing segment disclosures in Topic 280. This ASU is effective for fiscal years beginning after December
15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted
ASU 2023-07 on August 29, 2025, date of incorporation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
December&#160;2023, the FASB issued Accounting Standards Update 2023-09, &#x201c;Income Taxes (Topic 740): Improvements to Income Tax
Disclosure&#x201d; (&#x201c;ASU 2023-09&#x201d;). ASU 2023-09 mostly requires, on an annual basis, disclosure of specific categories in
an entity&#x2019;s effective tax rate reconciliation and income taxes paid disaggregated by jurisdiction. The incremental disclosures
may be presented on a prospective or retrospective basis. The ASU is effective for fiscal years beginning after December&#160;15, 2024
with early adoption permitted. The Company adopted the ASU 2023-09 on September 1, 2025, the beginning of its fiscal year. As a Cayman Island entity, the Company is not
subject to income taxes, as such, the Company did not have any material impact of adopting ASU 2023-09 on its financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Management
does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a
material effect on the Company&#x2019;s financial statements.&lt;/span&gt;&lt;/p&gt;

</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <TRAD:InitialPublicOfferingDisclosureTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000624">&lt;p id="xdx_80D_ecustom--InitialPublicOfferingDisclosureTextBlock_zTpuRk6i9RCe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
3 &#x2014; &lt;span id="xdx_827_z0bjkDzDwhW1"&gt;Initial Public Offering&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
February 27, 2026, the Company sold &lt;span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20260226__20260227__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zLz8Xl6AW5md" title="Number of units issued during period"&gt;11,197,131&lt;/span&gt; Units at a price of $&lt;span id="xdx_90F_eus-gaap--SaleOfStockPricePerShare_iI_c20260227__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z92sfdltQdf6" title="Offering price"&gt;10.00&lt;/span&gt; per Unit including the partial exercise of the over-allotment
option of &lt;span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20260206__20260227__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z5agR529dUjf" title="Number of units issued during period"&gt;1,197,131&lt;/span&gt; Units granted to the underwriters. Each Unit consists of one ordinary share with $&lt;span id="xdx_901_eus-gaap--SharePrice_iI_c20260227__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zbyrsxygKfda" title="Ordinary shares, shares par value"&gt;0.0001&lt;/span&gt; par value and one right
(the &#x201c;Public Right&#x201d;). Each Public Right entitles the holder to receive one-fourth (1/4) of one ordinary share upon the consummation
of the Company&#x2019;s initial Business Combination. The Company will not issue fractional shares upon conversion of the rights, as disclosed
in Note 7.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
April 10, 2026, the underwriters notified the Company of their exercise of the remaining balance of the over-allotment option to purchase
an additional &lt;span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20260409__20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zuyJSqMGGo57" title="Number of units issued during period"&gt;302,869&lt;/span&gt; Units at a price of $&lt;span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zsX7HLaaZMYd" title="Offering price"&gt;10.00&lt;/span&gt; per Unit. The closing of the over-allotment option occurred on April 15, 2026, generating
additional gross proceeds of $&lt;span id="xdx_905_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20260414__20260415__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zmf3cwZgrjha" title="Gross proceeds"&gt;3,028,690&lt;/span&gt;. Simultaneously with the closing of the over-allotment option, the Company consummated the private
placement of an aggregate of &lt;span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20260409__20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_ze5nojY2kYAf" title="Number of units issued during period"&gt;3,029&lt;/span&gt; units (the &#x201c;Private Placement Units&#x201d;) to the Sponsor, at a price of $&lt;span id="xdx_902_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zqMNlRsTp4M5" title="Offering price per share"&gt;10.00&lt;/span&gt; per Private
Placement Unit, generating gross proceeds of $&lt;span id="xdx_901_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20260409__20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zsuMBuWNLe67" title="Gross proceeds"&gt;30,290&lt;/span&gt;. As a result, the Company sold an aggregate of &lt;span id="xdx_90A_eus-gaap--PartnersCapitalAccountUnitsSoldInPublicOffering_pid_c20260409__20260410_zPnEY9tEdGtj" title="Public units issued during period"&gt;11,500,000&lt;/span&gt; Public Units in the IPO
and over-allotment, generating aggregate gross proceeds of $&lt;span id="xdx_903_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20260409__20260410__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zI2hnKpNH0fg" title="Gross proceeds"&gt;115,000,000&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</TRAD:InitialPublicOfferingDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="From2026-02-262026-02-27_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000626"
      unitRef="Shares">11197131</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2026-02-27_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000628"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="From2026-02-062026-02-27_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000630"
      unitRef="Shares">1197131</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:SharePrice
      contextRef="AsOf2026-02-27_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000632"
      unitRef="USDPShares">0.0001</us-gaap:SharePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="From2026-04-092026-04-10_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000634"
      unitRef="Shares">302869</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2026-04-10_us-gaap_OverAllotmentOptionMember"
      decimals="INF"
      id="Fact000636"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2026-04-142026-04-15_us-gaap_IPOMember"
      decimals="0"
      id="Fact000638"
      unitRef="USD">3028690</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2026-04-092026-04-10_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000640"
      unitRef="Shares">3029</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2026-04-10_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000642"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2026-04-092026-04-10_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact000644"
      unitRef="USD">30290</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PartnersCapitalAccountUnitsSoldInPublicOffering
      contextRef="From2026-04-092026-04-10"
      decimals="INF"
      id="Fact000646"
      unitRef="Shares">11500000</us-gaap:PartnersCapitalAccountUnitsSoldInPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="From2026-04-092026-04-10_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact000648"
      unitRef="USD">115000000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <TRAD:PrivatePlacementDisclosureTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000650">&lt;p id="xdx_809_ecustom--PrivatePlacementDisclosureTextBlock_zCmaDmCtueva" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
4 &#x2014; &lt;span id="xdx_82E_zjT9yJg4Jwj7"&gt;Private Placement&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Simultaneously
with the closing of the IPO and over-allotment, the Sponsor purchased an aggregate of &lt;span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250901__20260831__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zNVxnhO7RqY4" title="Private placement units issued during period"&gt;212,000&lt;/span&gt; Private Units in a private placement&#160;for
an aggregate purchase price of $&lt;span id="xdx_90F_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20250901__20260831__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zsqS25vWolna" title="Proceeds from issuance of private placement"&gt;2,120,000&lt;/span&gt;. Each Private Unit consists of one ordinary share (&#x201c;Private Share&#x201d;) and one right
to receive one-fourth (1/4) of one ordinary share upon the consummation of a Business Combination (&#x201c;Private Right&#x201d;). The
proceeds from the Private Units were added to the proceeds from the IPO to be held in the Trust Account. If the Company does not complete
a Business Combination within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption
of the Public Shares (subject to the requirements of applicable law), and the Private Units and all underlying securities will expire
worthless.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Private Units, Private Shares, Private Rights and the ordinary shares underlying such rights will not be transferable, assignable or
salable by the Sponsor until 30 days after the completion of the Company&#x2019;s initial Business Combination, except to permitted transferees.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</TRAD:PrivatePlacementDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-09-012026-08-31_us-gaap_PrivatePlacementMember"
      decimals="INF"
      id="Fact000652"
      unitRef="Shares">212000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2025-09-012026-08-31_us-gaap_PrivatePlacementMember"
      decimals="0"
      id="Fact000654"
      unitRef="USD">2120000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000656">&lt;p id="xdx_802_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zhcFCb2Jvm6i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
5 &#x2014; &lt;span id="xdx_82E_zbzA7u5h8u79"&gt;Related Party Transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Founder
Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;On August 29, 2025, the Sponsor agreed to acquire
&lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250829__20250829__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zd0Z9tJkKhk2" title="Private placement units issued during period"&gt;1,725,000&lt;/span&gt; ordinary shares (the &#x201c;Founder Shares&#x201d;) for an aggregate purchase price of $&lt;span id="xdx_900_ecustom--PaymentsForFounderSharesPurchasePrice_c20250829__20250829__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zY7HNzb2Z3wb" title="Purchase price"&gt;25,000&lt;/span&gt;, or approximately $&lt;span id="xdx_903_eus-gaap--SharePrice_iI_c20250829__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zm3tAEkkbQ6k" title="Price per share"&gt;0.0145&lt;/span&gt; per
share. Such ordinary shares were subsequently issued to the Sponsor on September 4, 2025. On January 21, 2026, the Company entered into
an amendment to the subscription agreement with the Sponsor for the purchase of an additional &lt;span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20260101__20260131__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zTR23S8v3Rpj" title="Shares additional issuance"&gt;1,150,000&lt;/span&gt; founder shares, resulting in a
total acquisition of &lt;span id="xdx_90F_ecustom--FounderSharesIssued_iI_pid_c20260131__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zhdGkUJnXoPk" title="Founder shares, issued"&gt;2,875,000&lt;/span&gt; ordinary shares for an aggregate consideration of $&lt;span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20260101__20260131__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zvuqlhvVbfai" title="Proceeds from issuance of common stock"&gt;25,000&lt;/span&gt;, or approximately $&lt;span id="xdx_906_eus-gaap--SharePrice_iI_c20260131__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zZvxzRlD57mb" title="Price per share"&gt;0.009&lt;/span&gt; per ordinary share.
Up to &lt;span id="xdx_904_ecustom--FounderSharesSubjectToForfeiture_c20260829__20260829__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zeqZHXhEtQ8h" title="Forfeiture"&gt;375,000&lt;/span&gt; founder shares were initially subject to forfeiture to the extent the underwriters&#x2019; over-allotment option was not
exercised in full. Following the full exercise of the underwriters&#x2019; over-allotment option, the Sponsor holds &lt;span id="xdx_90A_ecustom--FounderSharesIssued_iI_pid_c20260131__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zZEixSwVYjk2" title="Founder shares, issued"&gt;2,875,000&lt;/span&gt; founder shares,
none of which remains subject to forfeiture.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
initial shareholders have agreed, not to transfer, assign or sell &lt;span id="xdx_905_ecustom--SaleOfInitialShareholdersFounderSharesPercent_iI_pid_dp_uPure_c20250829_zXAzWdFlgRM8" title="Sale of initial shareholders founder shares, percent"&gt;100&lt;/span&gt;% of its Founder Shares until the earlier of (x) 180 days after
the date of the consummation of the Company&#x2019;s initial business combination or (y) the date on which the last reported sale price
of the Company&#x2019;s ordinary shares equals or exceeds $&lt;span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_c20250829__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zJhYv3jwC1Gc" title="Ordinary shares or exceeds price per share"&gt;12.00&lt;/span&gt; per share (as adjusted for share splits, share surrenders, reorganizations
and recapitalizations) for any 20 trading days within any 30-trading day period commencing at least 90 days after its initial business
combination, or (z) the Company consummates a subsequent liquidation, merger, share exchange or other similar transaction after its initial
Business Combination which results in all of its public shareholders having the right to exchange their ordinary shares for cash, securities
or other property.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Promissory
Note &#x2014; Related Party&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
August 31, 2025, the Sponsor agreed to loan the Company up to $&lt;span id="xdx_900_eus-gaap--NotesPayable_iI_c20250831__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_z2lIVjYwixua" title="Promissory note"&gt;500,000&lt;/span&gt;
(the &#x201c;Promissory Note&#x201d;) to be used for a portion of the expenses of the IPO. The Promissory Note is non-interest
bearing, unsecured and is due at the earlier of (1) March 31, 2026 or (2) the closing of the IPO, unless accelerated upon the
occurrence of an event of default. The Promissory Note was repaid upon the closing of the IPO out of the offering proceeds not held
in the Trust Account. As of August 31, 2026 and 2025, borrowings outstanding under the Promissory Note were $&lt;span id="xdx_904_ecustom--PromissoryNotesPayableRelatedPartyCurrent_iI_c20261031_zm18j58HBSp2" title="Promissory notes payable"&gt;0&lt;/span&gt; and $&lt;span id="xdx_90F_ecustom--PromissoryNotesPayableRelatedPartyCurrent_iI_c20251031_ziHkfss9pHW" title="Promissory notes payable"&gt;47&lt;/span&gt;, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Working
Capital Loans&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;In
addition, in order to finance transaction costs in connection with an intended initial Business Combination, the Sponsor, the Company&#x2019;s
officers and directors, or their affiliates/designees may, but are not obligated to, loan the Company funds, from time to time or at
any time, in whatever amount they deem reasonable in their sole discretion. If the Company completes the initial Business Combination,
it would repay such loaned amounts. In the event that the initial Business Combination does not close, the Company may use a portion
of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from the Trust Account would be used
for such repayment. Up to $&lt;span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueConversionOfUnits_c20250901__20260831__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_zeJlbkQuppa7" title="Working capital loans converted into private units"&gt;2,000,000&lt;/span&gt; of such working capital loans (&#x201c;Working Capital Loans&#x201d;) may be convertible into Private
Units, at a price of $&lt;span id="xdx_909_eus-gaap--SaleOfStockPricePerShare_iI_c20260831__us-gaap--RelatedPartyTransactionAxis__custom--SponsorMember_z8ZGpr8fUImk" title="Price per unit"&gt;10.00&lt;/span&gt; per Unit at the option of the lender, upon consummation of its initial Business Combination.&lt;/span&gt;&lt;/p&gt;


&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of August 31, 2026 and 2025, the Company had no borrowings under the Working Capital Loans.&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;A&lt;/b&gt;&lt;/span&gt;&lt;b&gt;mounts
Due to Related Party&lt;/b&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;During the year ended August 31, 2026, the Sponsor paid $&lt;span id="xdx_90B_ecustom--OperatingCostsPaidBySponsor_c20250901__20260831_zZY8HRmP9zCf" title="Operating costs paid by the Sponsor"&gt;176,167&lt;/span&gt; of operating
costs on behalf of the Company and loaned the Company $&lt;span id="xdx_90A_eus-gaap--Cash_iI_c20260820_zuc4xY4HBsd2" title="cash"&gt;5,000&lt;/span&gt; in cash on August 20, 2026. These amounts are non-interest bearing and due
on demand. Amounts due to the related party were $&lt;span id="xdx_90A_eus-gaap--OtherLiabilitiesCurrent_iI_c20260831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zpJU54HDjji5" title="Advances from a related party"&gt;181,167&lt;/span&gt; and $&lt;span id="xdx_90C_eus-gaap--OtherLiabilitiesCurrent_iI_c20250831__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zf56EgrePna1" title="Advances from a related party"&gt;0&lt;/span&gt; as of August 31, 2026 and 2025, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-08-292025-08-29_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000658"
      unitRef="Shares">1725000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <TRAD:PaymentsForFounderSharesPurchasePrice
      contextRef="From2025-08-292025-08-29_custom_FounderSharesMember"
      decimals="0"
      id="Fact000660"
      unitRef="USD">25000</TRAD:PaymentsForFounderSharesPurchasePrice>
    <us-gaap:SharePrice
      contextRef="AsOf2025-08-29_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000662"
      unitRef="USDPShares">0.0145</us-gaap:SharePrice>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2026-01-012026-01-31_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000664"
      unitRef="Shares">1150000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <TRAD:FounderSharesIssued
      contextRef="AsOf2026-01-31_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000666"
      unitRef="Shares">2875000</TRAD:FounderSharesIssued>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2026-01-012026-01-31_custom_FounderSharesMember"
      decimals="0"
      id="Fact000668"
      unitRef="USD">25000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SharePrice
      contextRef="AsOf2026-01-31_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000670"
      unitRef="USDPShares">0.009</us-gaap:SharePrice>
    <TRAD:FounderSharesSubjectToForfeiture
      contextRef="From2026-08-292026-08-29_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000672"
      unitRef="Shares">375000</TRAD:FounderSharesSubjectToForfeiture>
    <TRAD:FounderSharesIssued
      contextRef="AsOf2026-01-31_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000674"
      unitRef="Shares">2875000</TRAD:FounderSharesIssued>
    <TRAD:SaleOfInitialShareholdersFounderSharesPercent
      contextRef="AsOf2025-08-29"
      decimals="INF"
      id="Fact000676"
      unitRef="Pure">1</TRAD:SaleOfInitialShareholdersFounderSharesPercent>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2025-08-29_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000678"
      unitRef="USDPShares">12.00</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:NotesPayable
      contextRef="AsOf2025-08-31_custom_SponsorMember"
      decimals="0"
      id="Fact000680"
      unitRef="USD">500000</us-gaap:NotesPayable>
    <TRAD:PromissoryNotesPayableRelatedPartyCurrent
      contextRef="AsOf2026-10-31"
      decimals="0"
      id="Fact000682"
      unitRef="USD">0</TRAD:PromissoryNotesPayableRelatedPartyCurrent>
    <TRAD:PromissoryNotesPayableRelatedPartyCurrent
      contextRef="AsOf2025-10-31"
      decimals="0"
      id="Fact000684"
      unitRef="USD">47</TRAD:PromissoryNotesPayableRelatedPartyCurrent>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfUnits
      contextRef="From2025-09-012026-08-31_custom_SponsorMember"
      decimals="0"
      id="Fact000686"
      unitRef="USD">2000000</us-gaap:StockIssuedDuringPeriodValueConversionOfUnits>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="AsOf2026-08-31_custom_SponsorMember"
      decimals="INF"
      id="Fact000688"
      unitRef="USDPShares">10.00</us-gaap:SaleOfStockPricePerShare>
    <TRAD:OperatingCostsPaidBySponsor
      contextRef="From2025-09-01to2026-08-31"
      decimals="0"
      id="Fact000690"
      unitRef="USD">176167</TRAD:OperatingCostsPaidBySponsor>
    <us-gaap:Cash
      contextRef="AsOf2026-08-20"
      decimals="0"
      id="Fact000692"
      unitRef="USD">5000</us-gaap:Cash>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2026-08-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000694"
      unitRef="USD">181167</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="AsOf2025-08-31_us-gaap_RelatedPartyMember"
      decimals="0"
      id="Fact000696"
      unitRef="USD">0</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000698">&lt;p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zy0hgqLk1igf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
6 &#x2014; &lt;span id="xdx_82A_z240t8ngOlx5"&gt;Commitments and Contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Registration
Rights&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The holders of the Founder Shares and Private Units (and in each case holders
of their component securities, as applicable) will be entitled to registration rights pursuant to a registration rights agreement dated
February 25, 2026 requiring the Company to register such securities for resale (in the case of the Founder Shares, only after conversion
to the ordinary shares). The holders of these securities are entitled to make up to two demands, excluding short form demands, that the
Company registers such securities. In addition, the holders have certain &#x201c;piggy-back&#x201d; registration rights with respect to
registration statements filed subsequent to the completion of the initial Business Combination and rights to require the Company to register
for resale such securities pursuant to Rule 415 under the Securities Act. However, the registration rights agreement provides that the
Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable
Lock-up period. The Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Underwriter
Agreement&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company has granted the underwriter, a 45-day option from the date of the registration statement to purchase up to &lt;span id="xdx_908_ecustom--AdditionalUnitsOfOverAllotmentOption_iI_pid_c20260831__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zNhMzF18tPo" title="Additional units over-allotment option"&gt;1,500,000&lt;/span&gt; additional
Units to cover over-allotments, if any, at the IPO price less the underwriting discounts and commissions. The underwriter partially exercised
its over-allotment option on February 27, 2026, and exercised the remaining balance in full on April 15, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
underwriter was paid a cash underwriting discount of $&lt;span id="xdx_904_eus-gaap--DeferredSalesCommission_iI_c20260227__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z8WNZupqVlpb" title="Underwriting commissions (cash paid)"&gt;1,150,000&lt;/span&gt;, or &lt;span id="xdx_90D_ecustom--UnderwritingDiscountPercent_pid_dp_uPure_c20260226__20260227_zIKI3KHAEKLf" title="underwriting discount, percent"&gt;1.0&lt;/span&gt;% of the gross proceeds of the IPO, including the&#160;exercises
of its over-allotment option, upon the closing of IPO on February 27, 2026 and on April 15, 2026.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Representative&#x2019;s
Shares&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company also issued &lt;span id="xdx_905_ecustom--RepresentativeSharesIssued_pid_c20260201__20260227_zg0Tly3kw6b8" title="Representative shares, issued"&gt;50,000&lt;/span&gt; ordinary shares (including partial exercise of the over-allotment option) to the underwriter upon the consummation
of the IPO. These shares were registered in connection with the IPO. The underwriters have agreed
not to transfer, assign or sell any such shares until 180 days immediately following the commencement of sales of the IPO pursuant to
FINRA Rule 5110(e)(1), subject to exceptions pursuant to FINRA Rule 5110(e)(2).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Additionally,
the Company will issue to A.G.P. and/or its designee &lt;span id="xdx_904_ecustom--RepresentativeDesignatedSharesIssued_iI_pid_c20260227_zIgyRYrJKe79" title="Representative designates shares, issued"&gt;230,000&lt;/span&gt;
ordinary shares upon the closing of an initial business combination of the Company valued at $&lt;span id="xdx_901_eus-gaap--SharePrice_iI_pid_c20260227_zIPN1XhIaqZh" title="Offering price"&gt;10.00&lt;/span&gt;
per share as deferred compensation, without an additional cash payment by A.G.P., which are referred to herein as the &#x201c;deferred compensation shares&#x201d;. The representative has agreed not to
transfer, assign or sell any such shares until 180 days immediately following the commencement of sales of the IPO pursuant to FINRA
Rule 5110(e)(1), subject to exceptions pursuant to FINRA Rule 5110(e)(2). In addition, the representative has agreed (i) to waive
its redemption rights with respect to such shares in connection with the completion of the initial business combination and (ii) to
waive its rights to liquidating distributions from the Trust Account with respect to such shares if the Company fails to complete
its initial business combination within the Combination Period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
representative and deferred compensation shares have been deemed compensation by FINRA and are therefore subject to a lock-up for a period
of 180 days immediately following the date of commencement of sales of this offering pursuant to FINRA Rule 5110(e)(1). Pursuant to FINRA
Rule 5110(e)(1), these securities will not be sold during the offering, or sold, transferred, assigned, pledged, or hypothecated, or
be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of the securities
by any person for a period of 180 days immediately following the commencement of sales of the public offering, subject to exceptions
pursuant to FINRA Rule 5110(e)(2).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Right
of First Refusal&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company granted A.G.P., subject to certain conditions, for a period of twelve (12) months following the consummation of the initial business
combination, an irrevocable right of first refusal to act as sole investment banker, sole book runner, and/or sole placement agent, at
A.G.P.&#x2019;s sole discretion, for each and every future public and private equity and debt offering, including all equity linked financings
for us or any of our successors or subsidiaries, on terms customary to A.G.P. A.G.P. shall have the sole right to determine whether or
not any other broker dealer shall have the right to participate in any such offering and the economic terms of any such participation.
In accordance with FINRA Rule 5110(g)(6)(A), such right of first refusal shall not have a duration of more than three years from the
effective date of the registration statement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Finder&#x2019;s
Engagement Agreement&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
March 15, 2026, the Company entered into a non-exclusive Finder&#x2019;s Engagement Agreement (the &#x201c;Finder Agreement&#x201d;) with
California Hedge Fund Inc. (the &#x201c;Finder&#x201d;), pursuant to which the Finder agreed to identify and introduce potential business
combination targets to the Company and facilitate preliminary discussions in connection with a potential initial business combination.
Under the Finder Agreement, the Company agreed to pay the Finder a non-refundable retainer and, upon the consummation of an initial business
combination with a target introduced or identified by the Finder, a cash success fee. The Company also agreed to reimburse the Finder
for certain reasonable, documented out-of-pocket expenses, subject to specified limitations. The Finder Agreement contains customary
termination, confidentiality and other customary provisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On May 15, 2026, the Company and the Finder entered into &lt;span id="xdx_90F_eus-gaap--OtherCommitmentsDescription_c20260515__20260515_zw77zH50OOq" title="Commitments and contingencies amendment description"&gt;Amendment No. 1
to the Finder Agreement, which increased the aggregate non-refundable retainer payable to the Finder from $250,000 to $500,000, with the
remaining $250,000 becoming payable upon execution of the amendment in May 2026. Additionally, the cash success fee payable upon the consummation
of a Transaction as defined in the Finder Agreement was increased from $3.75 million to $4.5 million. Except as modified by Amendment
No. 1, the remaining terms of the Finder Agreement remained unchanged. As of August 31, 2026, the $500,000 non-refundable retainer was
fully paid&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Service
Agreement with Chief Executive Officer&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On July 20, 2026, the Company appointed Florence Ng as Chief Executive Officer
and entered into a Service Agreement providing a base salary of $&lt;span id="xdx_907_eus-gaap--SalariesAndWages_c20260720__20260720__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zM8cUQYS2pZ7" title="Base salary"&gt;5,000&lt;/span&gt; per month, reimbursement of reasonable business expenses and a
one-time $&lt;span id="xdx_907_ecustom--Bonus_c20260720__20260720__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zNxP8zLmnjwl" title="Bonus"&gt;400,000&lt;/span&gt; bonus payable within 30 days after successful completion of the initial Business Combination, in cash, equity or a combination
thereof. The agreement may be terminated by either party on 30 days&#x2019; written notice without affecting accrued compensation. The
Business Combination had not closed at August 31, 2026 and the completion bonus had not become payable.&lt;/span&gt;&lt;/p&gt;



</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <TRAD:AdditionalUnitsOfOverAllotmentOption
      contextRef="AsOf2026-08-31_us-gaap_IPOMember"
      decimals="INF"
      id="Fact000700"
      unitRef="Shares">1500000</TRAD:AdditionalUnitsOfOverAllotmentOption>
    <us-gaap:DeferredSalesCommission
      contextRef="AsOf2026-02-27_us-gaap_OverAllotmentOptionMember"
      decimals="0"
      id="Fact000702"
      unitRef="USD">1150000</us-gaap:DeferredSalesCommission>
    <TRAD:UnderwritingDiscountPercent
      contextRef="From2026-02-262026-02-27"
      decimals="INF"
      id="Fact000704"
      unitRef="Pure">0.010</TRAD:UnderwritingDiscountPercent>
    <TRAD:RepresentativeSharesIssued
      contextRef="From2026-02-012026-02-27"
      decimals="INF"
      id="Fact000706"
      unitRef="Shares">50000</TRAD:RepresentativeSharesIssued>
    <TRAD:RepresentativeDesignatedSharesIssued
      contextRef="AsOf2026-02-27"
      decimals="INF"
      id="Fact000708"
      unitRef="Shares">230000</TRAD:RepresentativeDesignatedSharesIssued>
    <us-gaap:SharePrice
      contextRef="AsOf2026-02-27"
      decimals="INF"
      id="Fact000710"
      unitRef="USDPShares">10.00</us-gaap:SharePrice>
    <us-gaap:OtherCommitmentsDescription contextRef="From2026-05-152026-05-15" id="Fact000712">Amendment No. 1
to the Finder Agreement, which increased the aggregate non-refundable retainer payable to the Finder from $250,000 to $500,000, with the
remaining $250,000 becoming payable upon execution of the amendment in May 2026. Additionally, the cash success fee payable upon the consummation
of a Transaction as defined in the Finder Agreement was increased from $3.75 million to $4.5 million. Except as modified by Amendment
No. 1, the remaining terms of the Finder Agreement remained unchanged. As of August 31, 2026, the $500,000 non-refundable retainer was
fully paid</us-gaap:OtherCommitmentsDescription>
    <us-gaap:SalariesAndWages
      contextRef="From2026-07-202026-07-20_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      id="Fact000714"
      unitRef="USD">5000</us-gaap:SalariesAndWages>
    <TRAD:Bonus
      contextRef="From2026-07-202026-07-20_srt_ChiefExecutiveOfficerMember"
      decimals="0"
      id="Fact000716"
      unitRef="USD">400000</TRAD:Bonus>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000718">&lt;p id="xdx_800_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_z5iVWv9lxB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
7 &#x2014; &lt;span id="xdx_82E_zNKa3C4CIb9c"&gt;Shareholders&#x2019; Equity&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Ordinary
Share&lt;/i&gt;&lt;/b&gt;&#x2014; The Company is authorized to issue &lt;span id="xdx_904_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20260831_zMclt6mGVhNc" title="Ordinary shares, shares authorized"&gt;600,000,000&lt;/span&gt; ordinary shares with $&lt;span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20260831_zZVYq2Xy9YOd" title="Ordinary shares, shares par value"&gt;0.0001&lt;/span&gt; par value. On August 29, 2025, the Company
agreed to issue &lt;span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20250829__20250829__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zP2vFKJlt4Rl" title="Private placement units issued during period"&gt;1,725,000&lt;/span&gt; Founder Shares to the Sponsor for an aggregate purchase price of $&lt;span id="xdx_90D_ecustom--PaymentsForFounderSharesPurchasePrice_c20250829__20250829__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zfrnRyfnTZdg" title="Purchase price"&gt;25,000&lt;/span&gt;, or $&lt;span id="xdx_905_ecustom--FounderSharesPricePerShare_iI_c20250829__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_ztN8VVp0wdxl" title="Price per share"&gt;0.0145&lt;/span&gt; per share. Such ordinary
shares were subsequently issued to the Sponsor on September 4, 2025. In January 2026, the Company entered into an amendment to the subscription
agreement with the Sponsor for the purchase of an additional &lt;span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesOther_pid_c20260101__20260131__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zLC5gf2lExJ8" title="Shares additional issuance"&gt;1,150,000&lt;/span&gt; ordinary shares, resulting in a total acquisition of &lt;span id="xdx_909_ecustom--FounderSharesIssued_iI_pid_c20260131__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zqSniedSfoqh" title="Founder shares, issued"&gt;2,875,000&lt;/span&gt;
ordinary shares for an aggregated consideration of $&lt;span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20260101__20260131__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zp7gFUV6OGw4" title="Proceeds from issuance of common stock"&gt;25,000&lt;/span&gt;, or approximately $&lt;span id="xdx_906_eus-gaap--SharesIssuedPricePerShare_iI_c20260131__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zhxkib4Clkbd" title="Price per share"&gt;0.009&lt;/span&gt; per ordinary share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;As
of August 31, 2026, there were &lt;span id="xdx_905_ecustom--FounderSharesIssued_iI_pid_c20260831__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_z5zWxcXySKg9" title="Founder shares, issued"&gt;2,875,000&lt;/span&gt; Founder Shares, &lt;span id="xdx_903_eus-gaap--CommonUnitIssued_iI_pid_c20260831__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_z4vnIWhW9Zk6" title="Ordinary shares, shares issued"&gt;50,000&lt;/span&gt; Representative Shares, and &lt;span id="xdx_90D_eus-gaap--SharesIssued_iI_pid_c20260831__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zW9K9mvUED3h" title="Private share issued"&gt;&lt;span id="xdx_90F_eus-gaap--SharesOutstanding_iI_pid_c20260831__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_zevtyxPrDMz1" title="Private share outstanding"&gt;212,000&lt;/span&gt;&lt;/span&gt; Private Shares issued and outstanding
(excluding &lt;span id="xdx_909_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20260831__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_z0ySzI1BGQXg" title="Ordinary shares subject to possible redemption, shares"&gt;11,500,000&lt;/span&gt; shares subject to possible redemption). As of August 31, 2025, there were &lt;span id="xdx_907_eus-gaap--SharesOutstanding_iI_pid_c20250831__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYg9ZjtOrcdl" title="Private share outstanding"&gt;2,875,000&lt;/span&gt; Founder Shares outstanding.
Founder Shares have been retroactively restated to reflect an amendment to the Subscription Agreement mentioned above.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Rights&lt;/i&gt;&lt;/b&gt;
&#x2014; Except in cases where the Company is not the surviving company in a business combination, each holder of a right will receive
one-fourth (1/4) of an ordinary share upon consummation of the initial business combination. In the event the Company will not be the
surviving company upon completion of its initial business combination, each holder of a right will be required to affirmatively convert
his, her or its rights in order to receive the one-fourth (1/4) of a share underlying each right upon consummation of the business combination
unless otherwise waived in the course of the business combination. No fractional shares will be issued upon exchange of rights. No additional
consideration will be required to be paid by a holder of rights in order to receive its additional shares upon consummation of a business
combination. Fractional shares will be rounded down to the nearest whole share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;If
the Company is unable to complete an initial Business Combination within the required time period and the Company liquidates the funds
held in the Trust Account, holders of rights will not receive any such funds with respect to their rights, nor will they receive any
distribution from the Company&#x2019;s assets held outside of the Trust Account with respect to such rights, and the rights will expire
worthless. As of August 31, 2026, there were&#160;&lt;span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260831__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_z6M0eFcljd4a" title="Rights outstanding"&gt;11,712,000&lt;/span&gt;&#160;rights outstanding, consisting of&#160;&lt;span id="xdx_905_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260831__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember__us-gaap--AwardTypeAxis__custom--PublicRightsMember_zZsVa1hMXfp" title="Rights outstanding"&gt;11,500,000&lt;/span&gt;&#160;public rights
and&#160;&lt;span id="xdx_900_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_c20260831__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember__us-gaap--AwardTypeAxis__custom--PrivateRightsMember_z2ASuz6sl1T1" title="Rights outstanding"&gt;212,000&lt;/span&gt; private rights. As of August&#160;31, 2025, there were&#160;&lt;span id="xdx_902_eus-gaap--ClassOfWarrantOrRightOutstanding_iI_pid_do_c20250831__us-gaap--StatementClassOfStockAxis__custom--FounderSharesMember_znX4ik6jrVwb" title="Rights outstanding"&gt;no&lt;/span&gt;&#160;rights outstanding.&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="AsOf2026-08-31"
      decimals="INF"
      id="Fact000720"
      unitRef="Shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="AsOf2026-08-31"
      decimals="INF"
      id="Fact000722"
      unitRef="USDPShares">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="From2025-08-292025-08-29_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000724"
      unitRef="Shares">1725000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <TRAD:PaymentsForFounderSharesPurchasePrice
      contextRef="From2025-08-292025-08-29_custom_FounderSharesMember"
      decimals="0"
      id="Fact000726"
      unitRef="USD">25000</TRAD:PaymentsForFounderSharesPurchasePrice>
    <TRAD:FounderSharesPricePerShare
      contextRef="AsOf2025-08-29_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000728"
      unitRef="USDPShares">0.0145</TRAD:FounderSharesPricePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesOther
      contextRef="From2026-01-012026-01-31_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000730"
      unitRef="Shares">1150000</us-gaap:StockIssuedDuringPeriodSharesOther>
    <TRAD:FounderSharesIssued
      contextRef="AsOf2026-01-31_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000732"
      unitRef="Shares">2875000</TRAD:FounderSharesIssued>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="From2026-01-012026-01-31_custom_FounderSharesMember"
      decimals="0"
      id="Fact000734"
      unitRef="USD">25000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2026-01-31_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000736"
      unitRef="USDPShares">0.009</us-gaap:SharesIssuedPricePerShare>
    <TRAD:FounderSharesIssued
      contextRef="AsOf2026-08-31_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000738"
      unitRef="Shares">2875000</TRAD:FounderSharesIssued>
    <us-gaap:CommonUnitIssued
      contextRef="AsOf2026-08-31_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000740"
      unitRef="Shares">50000</us-gaap:CommonUnitIssued>
    <us-gaap:SharesIssued
      contextRef="AsOf2026-08-31_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000742"
      unitRef="Shares">212000</us-gaap:SharesIssued>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2026-08-31_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000744"
      unitRef="Shares">212000</us-gaap:SharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="AsOf2026-08-31_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000746"
      unitRef="Shares">11500000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:SharesOutstanding
      contextRef="AsOf2025-08-31_custom_FounderSharesMember_us-gaap_CommonStockMember"
      decimals="INF"
      id="Fact000748"
      unitRef="Shares">2875000</us-gaap:SharesOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2026-08-31_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000750"
      unitRef="Shares">11712000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2026-08-31_custom_FounderSharesMember_custom_PublicRightsMember"
      decimals="INF"
      id="Fact000752"
      unitRef="Shares">11500000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2026-08-31_custom_FounderSharesMember_custom_PrivateRightsMember"
      decimals="INF"
      id="Fact000754"
      unitRef="Shares">212000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="AsOf2025-08-31_custom_FounderSharesMember"
      decimals="INF"
      id="Fact000756"
      unitRef="Shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000758">&lt;p id="xdx_800_eus-gaap--SegmentReportingDisclosureTextBlock_zGaM0uuSjcfa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
8 &#x2014; &lt;span id="xdx_824_zg0IPW4zq8Hi"&gt;Segment Information&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;ASC
Topic 280, &#x201c;Segment Reporting,&#x201d; establishes standards for companies to report in their financial statements&#x2019; information
about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of
an enterprise for which separate financial information is available that is regularly evaluated by the Company&#x2019;s chief operating
decision maker, or group, in deciding how to allocate resources and assess performance. The Company has adopted the guidance in ASU 2023-07,
Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, in the accompanying financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Through
July 20, 2026, the Company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;) was its Chief Executive Officer, Chief Financial
Officer and Chairman, which positions were then held by a single individual. Since July 20, 2026, the CODM consists of the Company&#x2019;s
Chief Executive Officer and its Chief Financial Officer and Chairman, who together review the operating results for the Company as a
whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the
Company only has &lt;span id="xdx_90A_eus-gaap--NumberOfOperatingSegments_dc_uSegment_c20250901__20260831_zo2cK6cm5zkk" title="Number of operating segments"&gt;&lt;span id="xdx_907_eus-gaap--NumberOfReportableSegments_dc_uSegment_c20250901__20260831_zMg3bO9Cn2o3" title="Number of reportable segments"&gt;one&lt;/span&gt;&lt;/span&gt; operating and reportable segment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_gL3SOSRIBSTB-DYW_zPdCHnaR5R8e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation the CODM reviews several key metrics,
which include the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zWrP4G17IP07"&gt;Schedule
of Performance and Making Key Decisions Regarding Resource Allocation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20250701__20260831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zgUoytpCLN08" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
                                            the &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;August
                     31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20250829__20250831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zD3gOm6D4Pd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;from&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August
                                            29, 2025&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Inception)&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;through&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August
                                            31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--GeneralAndAdministrativeExpense_zOzXlC0uo8Y9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;962,124&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,047&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--InvestmentTaxCredit_zMks8f9BsxHl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest earned on investments held in Trust
    Account&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,695,841&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0772"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AC_zpIS4cHgtzxf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
key measures of segment profit or loss reviewed by the CODM are general and administrative expenses. General and administrative expenses
are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital is available to complete a business combination
within the business combination period. The CODM also reviews general and administrative expenses to manage, maintain and enforce all
contractual agreements to ensure costs are aligned with all agreements and budget. Interest earned on investments held in Trust Account
are reviewed to measure and monitor shareholder value and determine the most effective strategy of investment with the Trust Account
funds while maintaining compliance with the trust agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
CODM also assesses performance for the single segment and decides how to allocate resources. The measure of segment assets is reported
on the balance sheet as total assets. When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation
the CODM reviews several key metrics included in total assets, which include the following:&lt;/span&gt;&lt;/p&gt;

&lt;div id="xdx_C01_gL3SOSRIBSTB-DYW_z7v5Hw7NbwCi"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20260831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zhy4JHvUFG75" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;August
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFBlcmZvcm1hbmNlIGFuZCBNYWtpbmcgS2V5IERlY2lzaW9ucyBSZWdhcmRpbmcgUmVzb3VyY2UgQWxsb2NhdGlvbiAoRGV0YWlscykA" id="xdx_400_eus-gaap--AssetsHeldInTrust_iI_zjh1kMMUj1gk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investments held in Trust Account&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,695,841&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;/div&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span id="xdx_C03_gL3SOSRIBSTB-DYW_z5jORXMNxrEi"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
CODM reviews the position of total assets available with the Company to assess if the Company has sufficient resources available to discharge
its liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="From2025-09-01to2026-08-31"
      decimals="INF"
      id="Fact000760"
      unitRef="Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="From2025-09-01to2026-08-31"
      decimals="INF"
      id="Fact000762"
      unitRef="Segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000766">&lt;p id="xdx_897_eus-gaap--ScheduleOfSegmentReportingInformationBySegmentTextBlock_gL3SOSRIBSTB-DYW_zPdCHnaR5R8e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;When
evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation the CODM reviews several key metrics,
which include the following:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;span id="xdx_8BE_zWrP4G17IP07"&gt;Schedule
of Performance and Making Key Decisions Regarding Resource Allocation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_496_20250701__20260831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zgUoytpCLN08" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;For
                                            the &lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Year
                                            Ended&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;August
                     31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20250829__20250831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zD3gOm6D4Pd" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;For
                                            the&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Period&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;from&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August
                                            29, 2025&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;(Inception)&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;through&lt;/span&gt;&lt;/p&gt;
                                                                                &lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;August
                                            31, 2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eus-gaap--GeneralAndAdministrativeExpense_zOzXlC0uo8Y9" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 60%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;General and administrative expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;962,124&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;17,047&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eus-gaap--InvestmentTaxCredit_zMks8f9BsxHl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Interest earned on investments held in Trust
    Account&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;1,695,841&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0772"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20260831__us-gaap--StatementBusinessSegmentsAxis__us-gaap--AllOtherSegmentsMember_zhy4JHvUFG75" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;August
                                            31,&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;2026&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFBlcmZvcm1hbmNlIGFuZCBNYWtpbmcgS2V5IERlY2lzaW9ucyBSZWdhcmRpbmcgUmVzb3VyY2UgQWxsb2NhdGlvbiAoRGV0YWlscykA" id="xdx_400_eus-gaap--AssetsHeldInTrust_iI_zjh1kMMUj1gk" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 80%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;Investments held in Trust Account&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 16%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;116,695,841&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&#160;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2025-07-012026-08-31_us-gaap_AllOtherSegmentsMember"
      decimals="0"
      id="Fact000768"
      unitRef="USD">962124</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="From2025-08-292025-08-31_us-gaap_AllOtherSegmentsMember"
      decimals="0"
      id="Fact000769"
      unitRef="USD">17047</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:InvestmentTaxCredit
      contextRef="From2025-07-012026-08-31_us-gaap_AllOtherSegmentsMember"
      decimals="0"
      id="Fact000771"
      unitRef="USD">1695841</us-gaap:InvestmentTaxCredit>
    <us-gaap:AssetsHeldInTrust
      contextRef="AsOf2026-08-31_us-gaap_AllOtherSegmentsMember"
      decimals="0"
      id="Fact000774"
      unitRef="USD">116695841</us-gaap:AssetsHeldInTrust>
    <us-gaap:SubsequentEventsTextBlock contextRef="From2025-09-01to2026-08-31" id="Fact000776">&lt;p id="xdx_800_eus-gaap--SubsequentEventsTextBlock_z8NOkcKLe4m9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Note
9 &#x2014; &lt;span id="xdx_825_ztVYQGcGTnha"&gt;Subsequent Events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements
were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events
that would have required adjustment or disclosure in the financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;On
October 20, 2026, the Company entered into an Agreement and Plan of Merger (the &#x201c;Merger Agreement&#x201d;) with APEX Tech Merger
Sub Inc., a Delaware corporation and wholly-owned subsidiary of the Company, the Sponsor, in its capacity as Purchaser Representative,
Korai Flix, Inc., a Delaware corporation (&#x201c;Korai&#x201d;), and Hongdae Lee, in his capacity as Company Representative. Pursuant
to the Merger Agreement, the Company will re-domicile as a Delaware corporation, and Merger Sub will merge with and into Korai, with
Korai surviving as a wholly-owned subsidiary of the Company, in exchange for aggregate merger consideration of $&lt;span id="xdx_906_eus-gaap--BusinessCombinationConsiderationTransferred1_c20261020__20261020__us-gaap--BusinessAcquisitionAxis__custom--KoraiFlixIncMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zuk2HHgn5gGj" title="Consideration payable"&gt;3,500,000,000&lt;/span&gt; payable
in newly issued shares of the Company valued at $&lt;span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20261020__us-gaap--BusinessAcquisitionAxis__custom--KoraiFlixIncMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zXnHmpLoikEe" title="Newly issued price per shares"&gt;10.00&lt;/span&gt; per share. The closing is subject to shareholder approval and other customary
conditions. In connection with the Merger Agreement, the Company also entered into a Sponsor Support Agreement and a Voting Agreement.&lt;/span&gt;&lt;/p&gt;

</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="From2026-10-202026-10-20_custom_KoraiFlixIncMember_us-gaap_SubsequentEventMember"
      decimals="0"
      id="Fact000778"
      unitRef="USD">3500000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="AsOf2026-10-20_custom_KoraiFlixIncMember_us-gaap_SubsequentEventMember"
      decimals="INF"
      id="Fact000780"
      unitRef="USDPShares">10.00</us-gaap:SharesIssuedPricePerShare>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000158"
          xlink:label="Fact000158"
          xlink:type="locator"/>
        <link:footnote id="Footnote000177" xlink:label="Footnote000177" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Ordinary
shares have been retroactively restated to reflect an amendment to the Subscription Agreement, pursuant to which the Sponsor increased
its founder shares from <xhtml:span
  id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250901__20260831__srt--RangeAxis__srt--MinimumMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zS92TWa5cxK"
  title="Ordinary shares issued">1,725,000</xhtml:span> to <xhtml:span
  id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250901__20260831__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zLIMe3Tuf4m6"
  title="Ordinary shares issued">2,875,000</xhtml:span> shares for an aggregate purchase price of $<xhtml:span
  id="xdx_902_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250901__20260831__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zZyOCaWjbpC1"
  title="Ordinary value issued">25,000</xhtml:span>. Initially, up to <xhtml:span
  id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20250901__20260831__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zZRWm3uJoO83"
  title="Forfeiture shares">375,000</xhtml:span> founder shares
were subject to forfeiture to the extent the underwriters&#x2019; over-allotment option was not exercised in full.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000158"
          xlink:to="Footnote000177"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000160"
          xlink:label="Fact000160"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000160"
          xlink:to="Footnote000177"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000227"
          xlink:label="Fact000227"
          xlink:type="locator"/>
        <link:footnote id="Footnote000242" xlink:label="Footnote000242" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Ordinary
shares have been retroactively restated to reflect an amendment to the Subscription Agreement, pursuant to which the Sponsor increased
its founder shares from <xhtml:span
  id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250901__20260831__srt--RangeAxis__srt--MinimumMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zl5BL7lnua"
  title="Ordinary shares issued">1,725,000</xhtml:span> to <xhtml:span
  id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250901__20260831__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zDMin7bpzo2f"
  title="Ordinary shares issued">2,875,000</xhtml:span> shares for an aggregate purchase price of $<xhtml:span
  id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250901__20260831__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zLEs7945RP64"
  title="Ordinary value issued"><xhtml:span
      id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250901__20260831__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zeY20EKe4QGj"
      title="Ordinary value issued">25,000</xhtml:span></xhtml:span>. Initially, up to <xhtml:span
  id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20250901__20260831__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zvTS5uDMtI0c"
  title="Forfeiture shares">375,000</xhtml:span> founder shares
were subject to forfeiture to the extent the underwriters&#x2019; over-allotment option was not exercised in full.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000227"
          xlink:to="Footnote000242"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000229"
          xlink:label="Fact000229"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000229"
          xlink:to="Footnote000242"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000231"
          xlink:label="Fact000231"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000231"
          xlink:to="Footnote000242"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000233"
          xlink:label="Fact000233"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000233"
          xlink:to="Footnote000242"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000260"
          xlink:label="Fact000260"
          xlink:type="locator"/>
        <link:footnote id="Footnote000357" xlink:label="Footnote000357" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Ordinary shares have been retroactively restated to
reflect an amendment to the Subscription Agreement, pursuant to which the Sponsor increased its founder shares from <xhtml:span
  id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250901__20260831__srt--RangeAxis__srt--MinimumMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zYgyI3gexFmb"
  title="Ordinary shares issued">1,725,000</xhtml:span> to <xhtml:span
  id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20250901__20260831__srt--RangeAxis__srt--MaximumMember__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zR2ROQn60Jk8"
  title="Ordinary shares issued">2,875,000</xhtml:span>
shares for an aggregate purchase price of $<xhtml:span
  id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20250901__20260831__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zwg8WB0rHKjh"
  title="Ordinary value issued">25,000</xhtml:span>. Initially, up to <xhtml:span
  id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20250901__20260831__us-gaap--TypeOfArrangementAxis__custom--SubscriptionAgreementMember_zFABHLt0LFEl"
  title="Forfeiture shares">375,000</xhtml:span> founder shares were subject to forfeiture to the extent the
underwriters&#x2019; over-allotment option was not exercised in full.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000260"
          xlink:to="Footnote000357"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000261"
          xlink:label="Fact000261"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000261"
          xlink:to="Footnote000357"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000262"
          xlink:label="Fact000262"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000262"
          xlink:to="Footnote000357"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000263"
          xlink:label="Fact000263"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000263"
          xlink:to="Footnote000357"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000327"
          xlink:label="Fact000327"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000327"
          xlink:to="Footnote000357"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000328"
          xlink:label="Fact000328"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000328"
          xlink:to="Footnote000357"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl0329"
          xlink:label="xdx2ixbrl0329"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl0329"
          xlink:to="Footnote000357"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000330"
          xlink:label="Fact000330"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000330"
          xlink:to="Footnote000357"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000332"
          xlink:label="Fact000332"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000332"
          xlink:to="Footnote000357"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
